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Session Key 
Each education session has been assigned an icon and number 
which corresponds to the format in which the session is 
presented. 
~ 100 series = Mini-Courses _$75 
rttH Half-day courses provide in-depth updates on 
, , , " relatively broad topics of major clinical interest, 
including clinical research data. The courses 
generally appeal to practicing and academic clinical 
cardiovascular specialists. 
111 200 series = Meet the Experts _ $35 These sessions are designed to provide scholarly yet informal interchanges of information between recognized authorities or workers in the field and a 
small group of cardiologists emphasizing maximum 
audience participation. Limited to 40 physicians and 
scientists only. 
FJ 
300 series = Luncheon Panels _$25 
Current practice issues in cardiovascular medicine are 
addressed by the session Chairman and four expert 
panelists. Questions and discussion follow. 
400 series = Special Sessions 
Among those spotlighted are the Opening Plenary 
Session, Clinical Decision Making, Young 
Investigators Awards Competition, Controversies in 
Cardiology, Annual Louis F. Bishop Lecture, and the 
Annual Convocation Lecture. 
B 
500 series = Fireside Panels 
Brief presentations are made by a Chairman and 
tJ. panelists who are involved in research related to the 
topic. Audience participation is an integral part of 
these informal, in-depth sessions. 
~ 600 series = Symposia Detailed discussions of cardiovascular topics and the results of large clinical trials are presented by 
individuals who have directly contributed information 
to the subject. 
~ 650 series = Core Curricula General, clinically oriented reviews and updates on the diagnosis and management of the most common 
cardiovascular disorders are presented. 
~ 70'''38 • Orig;nal ContribuUon,-O'al 
~ m ~840 = Original Contributions-Poster and Computer Applications _ Committee Booth Presentations 
Audio Tapes [ODO) 
Georgia World Congress Center, Hall E 
Audio tapes of selected sessions at ACC94, including 
Meet the Experts, will be available shortly after each 
session concludes and may be purchased at the audio 
tape desk. Taped sessions are identified by the above 
audio tape symbol and an order form will be available in 
the Final Program. 
Disclosure Statement 
Presenters whose names are accompanied by an 
asterisk (*) have indicated, in accordance with the 
Accreditation Council for Continuing Medical 
Education (ACCME) Standards and the policy of 
the American College of Cardiology, that they have 
a relationship which, in the context of their 
presentation, could be perceived by some people 
as a real or apparent conflict of interest, (e.g., 
ownership of stock, or research grants or 
consulting fees), but do not consider that it will 
influence their presentation. 
(+) A disclosure form had not been received from 
this presenter at time of printing. 
The American College of Cardiology Scientific Session is 
a scientific and educational meeting for the purpose of 
exchanging and discussing research results and scientific 
developments in the field of cardiovascular research. The 
views of the presenters at the Annual Scientific Session 
are those of the individual presenter and not necessarily 
those of the ACe. 
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Registration 
Saturday, March 12, 1994, 1 :00 p.m.-5:00 p.m. 
Georgia World Congress Center, Hall E 
Registration 
Sunday, March 13, 1994, 7:00 a.m.-6:00 p.m. 
Georgia World Congress Center, Hall E 
mil 
IMM Advanced Cardiac Life Support (ACLS) 
101 .10001 
Sunday, March 13, 1994, 8:00 a.m.-5:00 p.m. 
Georgia World Congress Center 
Co-Chairmen: W. Douglas Weaver, M.D., FACe., Univ. ofWA, 
Seattle, WA 
+Joseph P. Ornato, M.D., FACC, Med. Clg. of VA, 
Richmond, VA 
This seven hour session is intended for cardiologists who are interested 
in updating their skills on resuscitation and emergency cardiac care. 
The program will use the new American Heart Association ACLS case•
oriented teaching format customized to present information at a level 
of sophistication that is appropriate for cardiologists. The course 
format uses 10 "stations," each of which will have at least two ACLS 
instructors and 5-6 students at all times. Each station will present the 
students with a new case, and the instructors will teach the students 
how to expertly manage the case, including the use of emergency 
medical equipment (intubation, use of manual and automated 
defibrillators, etc.). The students will stay at each station 40-50 
minutes, then will rotate through the remaining stations one at a 
time. The session will break for lunch from Noon to 2:00 p.m. 
ACLS Stations and Cases 
1. Respiratory Arrest and IVTechniques 
2. Simple VF: AED and Manual Defibrillation 
3. RefractoryVF: Defibrillation, Drugs, Intubation 
4. PEAl Asystole 
5. Acute MI 
6. Bradycardias 
7. Tachycardias (Stable, Unstable) 
8. Supplemental Cases: Hypothermia, Trauma, Pregnancy, Drowning 
9. Megacode Practice and Evaluation 
10. Basic Life Support Review 
Be sure to check the 
Final Program for all location and 
program updates. 
* + See disclosure statement 
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mil What Are the Lessons Learned From 
IMM ClinicalTrialsinPTCA? _ (0 0 01 
102 
Sunday, March 13, 1994, 9:00 a.m.-Noon 
Georgia World Congress Center 
Chairman: Cindy L. Grines, M.D., FACC, William Beaumont 
Hosp., Royal Oak, MI 
This course is designed to update clinical cardiologists as well as 
interventionalists on important trials, identifying the role and results 
of PTCA compared to other therapies. Specifically, randomized trials 
comparing PTCA to directional atherectomy, stents and bypass surgery 
will be summarized. Pathophysiology of restenosis and medical or 
device-based methods for prevention of restenosis will be discussed. 
9:00 Caveats About the CAVEAT Atherectomy Trial-*Robert 
9:30 
10:00 
10:30 
10:45 
11 :15 
11:45 
mil 
IMM 
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D. Safian, M.D., FACC, William Beaumont Hosp., Royal 
Oak, MI 
Overview of Randomized Stent vs. PTCA Trials-*Martin 
B. Leon, M.D., FACC, Washington Hosp. Ctr., Washing•
ton, DC 
The Role of CABG vs. PTCA in Management of 
Multivessel Disease-Robert H. Jones, M.D., FACC, Duke 
Univ. Med. Ctr., Durham, NC 
Break 
Medical Treatments for Restenosis: Are Any Effective?•
David P. Faxon, M.D., FACC, Univ. of S. CA. Med. Ctr., Los 
Angeles, CA 
A Multi·Device Randomized Trial: Results of the ERBAC 
Study-Nicolaus J. Reifart, M.D., F.E.S.C, Red Cross Hosp. & 
HeartCtr., Frankfurt, GERMANY 
Discussion 
Mechanisms of Atrial Fibrillation: 
Consequences for Left Ventricular and 
Atrio-Nodal Function 
Sunday, March 13, 1994, 9:00 a.m.-Noon 
Georgia World Congress Center 
Chairman: Frits L. Meijler, M.D., Ph.D., FAe.e., Interuniv. Card. 
Inst., Utrecht, THE NETHERLANDS 
Atrial Fibrillation (AF) remains an enigma to clinicians and basic scientists 
alike. Three major problems are apparent: 
The variability of the pulse; is Starling's Law still valid? 
The pattern of atrial excitation. 
The role of the AV node; does concealed conduction really exist? 
Results of studies with the nuclear stethoscope and quantitative 
cineangiography of left ventricular function will be presented. New 
methods to analyze atrial excitation pattern will be demonstrated. 
Discussed will be the question whether or not during AF the AV node 
conducts. This course will shed new light on this clinically, highly 
relevant arrhythmia. 
9:00 Left Ventricular Function: Beat to BeatAnalysis-Suzanna 
M.C Hardman, M.B., B.S., PhD., Univ. Clg. London Med. Sch., 
London, UNITED KINGDOM 
9:20 Left Ventricular Function: Stroke Volume Variations•
A.T. Marcel Gosselink, M.D., Univ. Hosp., Groningen, THE 
NETHERLANDS 
9:40 Morphology of the A VNode-Thomas N. James, M.D., 
FACe., Univ. ofTX, Galveston, TX 
iv PROGRAM 
10:00 Break 
10:30 Atrial and AV Nodal Excitation-Jose Jalife, M.D., State 
Univ. of NY, Syracuse, NY 
10:50 A trio ventricular Node; Conduction: Yes/-Douglas P. Zipes, 
M.D., FACC, IN Univ. Sch. of Med., Indianapolis, IN 
11: 1 0 Atrioventricular Node; Conduction: No/-Frits L. Meijler, 
M.D., Ph.D., FACC, Interuniv. Card. Inst., Utrecht, THE 
NETHERLANDS 
11 :30 
Jfm ..... 
104 
Discussion 
Nuclear Cardiology: Advances in 
Assessment of Myocardial Perfusion and 
Viability _ IODoj 
Sunday, March 13, 1994, 9:00 a.m.-Noon 
Georgia World Congress Center 
Chairman: James L. Ritchie, M.D., FACC, Univ. of WA Sch. of 
Med., Seattle, WA 
This course is designed to review new developments in the field of 
Nuclear Cardiology and detail their clinical application in the evolution 
and management of patients with suspected or known ischemic heart 
disease. In-depth presentations and critiques will be made on the new 
perfusion and pharmacologic stress agents and their current applica•
tions for diagnosis, prognosis and risk assessment in cardiac patients. 
The evolving role of perfusion imaging for assessing therapy and 
prognosis in acute myocardial infarction will be presented. Finally, a 
comparison will be made between conventional radionuclide methods 
and positron emission tomographic approaches to the assessment of 
myocardial viability. This Mini-Course will be of interest to the 
practicing clinical cardiologist who will be updated on the new 
developments in Nuclear Cardiology and their clinical application, as 
well as those cardiologists involved in the practice of Nuclear Cardiol•
ogy. 
9:00 Myocardial Perfusion Imaging for Ischemic Heart 
Disease-*Mario S. Verani, M.D., FACC, Baylor Clg. of 
Med., Houston, TX 
9: 30 Principles and Practice of Pharmacologic Perfusion 
Imaging-Manuel Decastro Cerqueira, M.D., FACC, Univ. of 
WA, Seattle, WA 
10:00 Perfusion Imaging in Acute Myocardial Infarction: 
Assessment of Therapy and Prognosis-* Raymond J. 
Gibbons, M.D., FACC, Mayo Clin., Rochester, MN 
10:30 Break 
10:45 Assessment of Myocardial Viability: Conventional 
RadionuclideMethods-RobertO. Bonow, M.D., FACC, 
Northwestern Univ. Med. Sch., Chicago, IL 
11 : 1 5 Assessment of Myocardial Viability: Positron Emission 
Tomography-Heinrich R. Schelbert, M.D., Ph.D., FACC, 
Univ. of CA Sch. of Med., Los Angeles, CA 
11 :45 Discussion 
Jfm Innovations in Cardiovascular Clinical 
..... Pharmacology _ JODOj 
105 
Sunday, March 13, 1994,9:00 a.m.-Noon 
Georgia World Congress Center 
Chairman: *Bertram Pitt, M.D., FACC, Univ. of MI Med. Ctr., 
Ann Arbor, MI 
This Mini-Course will review some of the important recent advances in 
clinical pharmacology in the areas of heart failure, arrhythmias, ischemic 
heart disease, and hypertension. Emphasis will be placed on advances 
in cardiovascular pharmacology, results of clinical trials, and practical 
application of the data to clinical care for the practicing cardiologist. 
* + See disclosure statement 
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9:00 Heart Failure: New Advances in the Mechanism and Role 
of Beta Adrenergic Blocking Agents in Heart Failure•
Michael R. Bristow, M.D., Ph.D., FACC, Univ. of CO Hlth. Sci. 
Ctr., Denver, CO 
9:30 Blockade of the Renin Angiotensin System in Heart 
Failure-Review of Current Clinical Trials and New 
PharmacologicaIApproaches-*Bertram Pitt, M.D., FACC, 
Univ. of MI Med. Ctr., Ann Arbor, MI 
10:00 Ischemic Heart Disease: Antiplatelet Strategies in Patients 
With Unstable Angina Pectoris and Myocardial 
Infarction-* James H. Chesebro, M.D., FACC, MA Gen. 
Hosp., Boston, MA 
10:30 Break 
10:45 Arrhythmias: Type 11/ Antiarrhythmic Agents-Review of 
New Agents in Use in Patients With Supraventricular and 
VentricularArrhythmias-* Albert L. Waldo, M.D., FACC, 
Univ. Hosps. of Cleveland, Cleveland, OH 
11 : 1 5 Hypertension: Regression of Left Ventricular Hypertro•
phy-Benefits and Effect of Pharmacologicallnterven•
tion-Edward D. Frohlich, M.D., FACC, Ochsner Clin., New 
Orleans, LA 
11 :45 Discussion 
Review of Clinical Trialsfor Acute Jfm Myocardial Infarction: Reperfusion, 
..... Adjunctive Therapy, and PTCA 
106 _~ 
Sunday, March 13, 1994, 9:00 a.m.-Noon 
Georgia World Congress Center 
Chairman: William J. Rogers, M.D., FACC, Univ. of AL at 
Birmingham, Birmingham, AL 
No field in cardiology, and perhaps all of medicine, has been investi•
gated as intensively over the past decade as acute myocardial infarction. 
Clinical trials, involving tens of thousands of patients from around the 
world, have contributed enormously to our understanding of the 
pathophysiology of myocardial infarction and, importantly, have also 
provided practical guidelines for treating patients to ensure optimal 
outcome. 
This Mini-Course will address each of the major areas of clinical trial 
investigation in myocardial infarction over the past decade: 
patient selection for thrombolysis 
optimal thrombolytic regimen 
appropriate ancillary pharmacotherapy 
role of primary angioplasty 
use of PTCA following thrombolytic therapy. 
9:00 Which Patients Should Receive Thrombolytic Therapy for 
AMI?-Nisha Chandra, M.D., Johns Hopkins, Baltimore, MD 
9:30 Which Is the Optimal Thrombolytic Regimen in 1994 and 
What Are the Prospects for the Future?-Eric J. Topol, 
M.D., FACC, Cleveland Clin. Fdn., Cleveland, OH 
10:00 WhatPharmacologicAgents, Other Than Thrombolytics, 
Improve the Outcome of Patients With AMI?-Salim Yusuf, 
M.B., B.S., Ph.D., FACC, McMaster Univ., Hamilton, 
CANADA 
10:30 Break 
10:45 What Is the Role of Primary Angioplasty?-David R. 
Holmes, Jr., M.D., FACC, Mayo Clin., Rochester, MN 
11 : 1 5 When Is It Appropriate to Perform PTCA Following 
Thrombolytic Therapy?-Stephen G. Ellis, M.D., FACC, 
Cleveland Clin. Fdn., Cleveland, OH 
11 :45 Discussion 
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~ Sudden Cardiac Death: Clinical Algorithms 
tHH for Diagnosis and Treatment-1994 and 
~1995 _~ 
107 
Sunday, March 13, 1994, 9:00 a.m.-Noon 
Georgia World Congress Center 
Chairman: James D. Maloney, M.D., FACe., Baylor Clg. of Med., 
Houston, TX 
Algorithms for diagnosing and treating survivors of sudden cardiac 
death must address various factors that include underlying structural 
heart disease, ventricularfunction, available alternative therapy, relative 
value of programmed ventricular stimulation, and utilization of 
therapies alone or in combination. 
The clinical algorithms are intended as guides to clinical practice and 
should not be utilized as guidelines for reimbursement and/or 
guidelines to assess legal responsibilities. The practice algorithms 
include step-wise approaches that may be surpassed or bypassed to 
facilitate efficient and effective therapy. 
9:00 Instantaneous Cardiac Death and Clinical Correlates•
Arthur J. Moss, M.D., FACe., Univ. of Rochester Med. Ctr., 
Rochester, NY 
9:30 Pro-Arrhythmia and Iatrogenic Sudden Cardiac Death: 
Patient Subsets-Identification and Prevention-+Craig M. 
Pratt, M.D., FACC, Baylor Clg. of Med., Houston, TX 
10:00 Choice of Drugs and Techniques for Assessing Drug 
Efficacy-Jayw. Mason, M.D., FACC, Univ. of UT Med. Ctr., 
Salt Lake City, UT 
10:30 Break 
10:45 teD Therapy for Prevention of Sudden Cardiac Death: 
AnalysisofOutcomes-* Jeremy N. Ruskin, M.D., FACe., 
MA Gen. Hosp., Boston, MA 
11: 15 Sudden Cardiac Death: Clinical Algorithms for Diagnosis 
and Treatment-1994 and 1995-James D. Maloney, M.D., 
FACC, Baylor Clg. of Med., Houston, TX 
11 :45 Discussion 
mil Molecular Biology and Geneticsforthe 
~ Clinical Cardiologist _ topol 
108 
Sunday, March 13, 1994, 9:00 a.m.-Noon 
Georgia World Congress Center 
Chairman: Robert Roberts, M.D., FACe., Baylor Clg. of Med., 
Houston, TX 
The techniques of recombinant DNA and molecular biology are rapidly 
advancing upon us and the application of these techniques is likely to 
playa major role in the understanding and treatment of several 
disorders such as atherosclerosis, inherited disorders, cardiomyopathies, 
restenosis following angioplasty and thrombolysis. The course is 
targeted for the cardiologist and trainee who would like to be 
acquainted with the terminology of molecular biology as well as an 
overview of some of the research ongoing in molecular cardiology. The 
molecular basis for the cardiac growth response induced by pressure or 
volume overload will be discussed as will the role of growth factors in 
mediating atherosclerosis, smooth muscle restenosis and hyperten•
sion-induced intensive hyperplexia. In the application of linkage 
analysis and positional cloning to identify the gene responsible for 
inherited disorders such as HCM or familial dilated cardiomyopathy 
(DCM) it is essential that the physician playa major role in collecting 
the families, obtaining the family history and performing the specific 
and appropriate diagnostic procedures. The physician's role is pivotal 
in future efforts to isolate genes for hereditary disorders of which 
there are more than 70 at present known to affect the heart. The 
course will include a brief session on linkage analysis and positional 
cloning together with other techniques of molecular genetics. 
* + See disclosure statement 
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Recent use of gene transfer and the potential to design and target 
specific drugs for the treatment of restenosis will also be discussed. 
9 :00 General Procedures Performed in Molecular Biology-
Andrew R. Marks, M.D., FACe., Mt. Sinai Med. Ctr., New 
York, NY 
9:25 Essentials of Molecular Genetics of Cardiac Growth•
Jeffrey Towbin, M.D., Baylor Clg. of Med., Houston, TX 
9: 50 Essentials of Molecular Genetics of Inherited Disorders•
*Robert Roberts, M.D., FACe., Baylor Clg. of Med., Houston, 
TX 
10:15 Break 
10:35 Overview of Gene Transfer-* Jeffrey Leiden, M.D., Ph.D., 
Univ. of Chicago, Chicago, IL 
11 :00 Molecular Genetics of the Vessel Wall-+Robert Wayne 
Alexander, M.D., Ph.D., FACe., Emory Univ., Atlanta, GA 
11 :25 Discussion 
mil Advances in Cardiac Imagingfor 
~ Congenital Heart Disease _ 100001 
109 
Sunday, March 13, 1994, 9:00 a.m.-Noon 
Georgia World Congress Center 
Chairman: David J. Sahn, M.D., FACC, OR Hlth. Sci. Univ., 
Portland, OR 
Major advances, both in ultrasound and Magnetic Resonance Imaging, 
provide new capabilities for imaging the heart in fetuses and in children 
and adults with congenital heart disease. This Mini-Course will review 
advances in technologies for defining cardiac anatomy and physiology, 
pre- and peri-operatively, for advancing prenatal diagnosis and 
management, and for planning and evaluating interventional cardiac 
catheterization procedures for congenital heart abnormalities. Presenta•
tions will stress high resolution advances in precordial transesophageal 
and intravascular ultrasound imaging and new modalities for MRI 
investigations. The implementation and contributions of 3-Dimensional 
reconstruction and how it clarifies congenital heart disease structure and 
function will be emphasized. A faculty of clinicians, pathologists, adult 
and pediatric cardiologists and biomedical engineering specialists will 
present the latest developments and a panel discussion. 
v 
9:00 Prenatal Diagnosis and Management of Congenital Heart 
Disease-Norman H. Silverman, M.D., FACC, Univ. of CA-San 
Francisco, San Francisco, CA 
9:30 Transesophageal Echocardiography High Resolution 
Technologies Suitable for Investigation in Children and 
InfantS-Stephen Sanders, M.D., Children's Hosp., Boston, 
MA 
10:00 Clinical Applications of Intravascular Ultrasound in 
Congenital Heart Disease: Insights Into Anatomy and the 
Effects of Transcatheter Interventions-David J. Sa h n, M.D., 
FACC, OR Hlth. Sci. Univ., Portland, OR 
10:30 Break 
10:45 Contributions of Magnetic Resonance Imaging to 
Diagnosis and Management of Congenital Heart Disease: 
New Approaches for Defining Anatomy and Physiology•
Paul M. Weinberg, M.D., Children's Hosp. of Phila., 
Philadelphia, PA 
11: 15 Applications of 3-Dimensional Ultrasound Imaging for 
Improved Understanding of Congenital Heart Disease•
Technical Considerations-James Greenleaf, Ph.D., Mayo 
Clin., Rochester, MN 
11 : 2 5 Applications of 3-Dimensional Ultrasound Imaging for 
Improved Understanding of Congenital Heart Disease•
Clinicallmplications-James B. Seward, M.D., FACe., Mayo 
Clin., Rochester, MN 
11 :45 Discussion 
vi 
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PROGRAM 
11th Annual Symposium for 
Directors of Pediatric Cardiology 
Programs (Luncheon) 
Sunday, March 13, 1994, Noon-2:00 p.m. 
Georgia World Congress Center, 368W 
By in vitation only. 
C ACCECG Proficiency Test (ACCEPT) 
402 
Sunday, March 13, 1994, 1 :00 p.m.-6:30 p.m. 
Atlanta Hilton & Towers, Grand Ballroom Salon 
lim Congenital Heart Disease-New Insights 
IMII Into Etiology and Morphogenesis 
110 _ locol 
Sunday, March 13, 1994, 2:00 p.m.-5:00 p.m. 
Georgia World Congress Center 
Chairman: Jacqueline A. Noonan, M.D., FACC, Univ. of KY 
Med. Ctr., Lexington, KY 
Exciting new epidemiologic data, coupled with renewed interest in the 
developmental mechanisms of cardiac morphogenesis, have begun to 
shed light on the etiology and morphogenesis of congenital cardiovascu•
lar malformations. The speakers will review recent clinical studies, 
update the important role of the neural crest in cardiac development, 
demonstrate how fetal ultrasound has contributed to our understand•
ing, and discuss from the pathologist's vantage how specific defects 
affect cardiovascular morphogenesis. This course is designed to 
encourage and allow ample discussion between audience and speaker 
and should be of interest to all physicians interested in congenital heart 
disease. 
2:00 Epidemiologic Update-Jacqueline A. Noonan, M.D., 
FACC, Univ. of KY Med. Ctr., Lexington, KY 
2:30 Neural Crest-Linda Leatherbury, M.D., FACC, Med. Clg. of 
GA, Augusta, GA 
3:00 Fetal Ultrasound-Charles S. Kleinman, M.D., FACC, Yale 
Univ., New Haven, CT 
3:30 Break 
3:45 Pathologist's Perspective-William N. O'Connor, M.B., B.Ch., 
FACC, Univ. of KY, Lexington, KY 
4: 15 Discussion 
lim Electrocardiography-ECG Analysis of 
IMII Complex Arrhythmias and Patterns 
111 _~ 
Sunday, March 13, 1994,2:00 p.m.-5:00 p.m. 
Georgia World Congress Center 
Advanced electrocardiography is the focus of this Mini-Course. 
Unknown tracings selected by the chairman serve as a point of 
departure for discussion of the diagnosis, mechanism and clinical 
relevance. Occasional HIS electrograms will be used to clarify or support 
the ECG diagnosis. Arrhythmia topics include, among others, all forms 
of aberration, wide and narrow QRS tachycardias, concealed conduc•
tion, reentry, parasystole, A-V block and A-V dissociation. Similarly, 
examples of patterns include fascicular blocks, bilateral BBB, non•
infarction Q waves, effect of IVCD on MI, unusual manifestations of MI, 
W-P-W, electrolyte disturbances and the abnormal U wave. This 
* + See disclosure statement 
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course will be of interest to all physiCians wishing to review and/or 
upgrade their ECG skills. Audience participation is strongly 
encouraged. 
Chairman: Charles Fisch, M.D., FACC, IN Univ. Sch. of Med., 
Indianapolis, IN 
Participants: Paul L. McHenry, M.D., FACC, IN Univ. Sch. of Med., 
Indianapolis, IN 
William M. Miles, M.D., FACC, IN Univ. Sch. of Med., 
Indianapolis, IN 
David P. Rardon, M.D., FACC, IN Univ. Sch. of Med., 
Indianapolis, IN 
Etienne O. Robles De Medina, M.D., Ph.D, FACC, Univ. 
Hosp., Utrecht, THE NETHERLANDS 
Douglas P. Zipes, M.D., FACC, IN Univ. Sch. 
of Med., Indianapolis, IN 
lim What Are the Lessons Learned From 
IMII ClinicalTrialsinRestenosis? _ ~:J 
112 
Sunday, March 13, 1994, 2:00 p.m.-5:00 p.m. 
Georgia World Congress Center 
Chairman: David P. Faxon, M.D., FACe., Univ. of S. CA Med. 
Ctr., Los Angeles, CA 
More than 50 trials have been conducted in an effort to resolve 
restenosis. To date, none have been successful. This Mini-Course will 
discuss the clinical trials and critique the problems in study design, 
endpoints, pharmacology and pathophysiology. The use of animal 
models to study restenosis, the role of local drug delivery, and new 
pharmacological and mechanical approaches to prevention including 
gene therapy will be discussed in lectures and in a group discussion. 
2: 00 A Review of Clinical Studies: What Have We Learned 
About Study Design?-*Robert M. Califf, M.D., FACe., 
Duke Univ. Med. Ctr., Durham, NC 
2:30 Lessons Learned From Quantitative Coronary 
Arteriography-Patrick W. Serruys, M.D., FACC, Erasmus 
Univ., Rotterdam, THE NETHERLANDS 
3:00 Pharmacologic Issues: A Case for Local Delivery-Jesse W. 
Currier, M.D., FACC, Univ. of S. CA Med. Ctr., Los Angeles, 
CA 
3:20 Break 
3:35 Pathophysiology: Do We Really Understand It?-David P. 
Faxon, M.D., FACC, Univ. of S. CA Med. Ctr., Los Angeles, 
CA 
4:00 NewDirectionsinPrevention-EricJ. Topol, M.D., FACC, 
The Cleveland Clin. Fdn., Cleveland, OH 
4:30 Discussion 
lim Advances in Vascular Biology: Implications 
IMII forthe Clinical Cardiologist _ locoj 
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Sunday, March 13, 1994, 2:00 p.m.-5:00 p.m. 
Georgia World Congress Center 
Chairman: *Victor J. Dzau, M.D., FACC, Stanford Univ. Sch. of 
Med., Stanford, CA 
This Mini-Course will focus on the concept of vascular biology and its 
application to cardiovascular medicine. New information on the 
maintenance of homeostasis of the vessel wall and the pathobiological 
events that result in vascular diseases will be introduced. The speakers 
will discuss the following topics: 
the utility of molecular biology in providing new pathophysiologic 
insights and therapies 
the role of the endothelium in the modulation of flow and pressure 
the regulation of vascular cell growth and migration in the 
pathogenesis of vascular disease 
the role of vascular mediators in the etiology of myocardial ischemia 
new insights into the pathobiology of restenosis after angioplasty. 
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2:00 
2:30 
3:00 
3:30 
3:45 
4:15 
4:45 
Concepts and Potentials of Vascular Biology-Overview•
*Victor J. Dzau, M.D., FACC, Stanford Univ. Sch. of Med., 
S ta nford, CA 
Endothelium and Coronary Blood Flow-*David Harrison, 
M.D., Emory Univ. Hosp., Atlanta, GA 
Current Concepts of Atherogenesis-Peter Li bby, M. D., 
FACC, Brigham & Women's Hosp., Boston, MA 
Break 
Vascular Biology of Acute Ischemic Syndrome-Valentin 
Fuster, M.D., Ph.D., FACe., Mt. Sinai Med. Ctr., New York, 
NY 
Vascular Biology for the Interventionalist-* Jeffrey M. 
Isner, M.D., FACC, st. Elizabeth's Hosp., Boston, MA 
Discussion 
rim Echocardiography: New Techniques and 
..... New Technology, Transesophageal Echo 
114 _ 10Doj 
Sunday, March 13, 1994, 2:00 p.m.-5:00 p.m. 
Georgia World Congress Center 
Chairman: * A. Jamil Tajik, M.D., FACe., Mayo Clin., Rochester, 
MN 
Ultrasound techniques and technology have progressed at a rapid pace 
in the past several years. These new technologies hold great promise 
for profound impact on the clinical decision making process. An expert 
faculty will present the state-of-the-art of multi plane TEE, intravascular/ 
intracardiac echocardiography, contrast echo for myocardial perfusion, 
3-D and 4-D reconstruction, and acoustic quantitation using tissue 
characterization. 
2:00 Overview-* A. Jamil Tajik, M.D., FACe., Mayo Clin., 
Rochester, MN 
2: 15 3-D, 4-D-James B. Seward, M.D., FACC, Mayo Clin., 
Rochester, MN 
2:45 TEE Multiplane-Harry Rakowski, M.D., Toronto Hosp., 
Toronto, CANADA 
3: 1 5 Tissue Characterization and Acoustic Quantitation•
*Richard L. Popp, M.D., FACC, Stanford Univ. Med. Ctr., 
Stanford, CA 
3:45 Break 
4:00 Intravascular/lntracardiac-Natesa G. Pandian, M.D., 
FACe., Tufts-New England Med. Ctr., Boston, MA 
4:30 Myocardial Perfusion and Contrast Echo-Sanjiv Kaul, 
M.B.B.S., FACC, Univ. of VA, Charlottesville, VA 
~ The Impact of Recent Clinical Trials in 
PfHt Heart Failure on Decision Making and the 
..... Approval of New Drugs _ ~ 
115 ~ 
Sunday, March 13, 1994,2:00 p.m.-5:00 p.m. 
Georgia World Congress Center 
Chairman: +Milton Packer, M.D., FACC, Columbia Univ., New 
York, NY 
There is a great need for new drugs for the treatment of chronic heart 
failure, and many agents have been developed that improve cardiac 
function as well as symptoms. However, the results of recent trials 
indicate that drugs that improve ventricular function may exert adverse 
effects on survival. This observation will have a major impact on the 
development of new drugs for this disorder and their consideration for 
approval by the Food and Drug Administration. These issues are of 
great importance to all physicians who care for patients with heart 
failure and will be discussed thoroughly by a faculty of clinical 
investigators with extensive experience in the regulatory process. 
* + See disclosure statement 
2:00 
2:25 
2:50 
3:10 
PROGRAM 
Guidelines for the Development of New Drugs for the 
Treatment of Chronic Heart Failure-+M i Iton Packer, M. D., 
FACC, Columbia Univ., New York, NY 
vii 
Results of Recent Survival Trials in Heart Failure: View 
of the Cardio-Renal Advisory Committee-*Barry M. 
Massie, M.D., FACC, Univ. of CA-San Francisco, San 
Francisco, CA 
Results of Recent Survival Trials in Heart Failure: 
Impact on Clinical Medicine and Investigation-Jay N. 
Cohn, M.D., FACC, Univ. of MN Med. Sch., Minneapolis, 
MN 
Impact of Survival Trials With Antiarrhythmic Drugs on 
Clinical Investigation and the Approval of Antiarrhythmic 
Drugs-Craig M. Pratt, M.D., FACC, Baylor Clg. of Med, 
Houston, TX 
3:30 Break 
3:45 
4:05 
Impact of Recent Trials in Heart Failure on the Approval 
of New Drugs: Viewpoint of the FDA-Raymond J. Lipicky, 
M.D., Food and Drug Admin., Rockville, MD 
Discussion 
~ The Many Faces of Atrial Fibrillation•
PfHt Flutter: Mechanisms, Treatment, 
..... Anti-Coagulation _ ~ 
116 ~ 
Sunday, March 13, 1994, 2:00 p.m.-5:00 p.m. 
Georgia World Congress Center 
Chairman: * Albert L. Waldo, M.D., FACC, Univ. Hosps. of 
Cleveland, Cleveland, OH 
Atrial fibrillation and flutter are remarkably common arrhythmias 
recognized since the first decade of this century. However, understand•
ing and treatment of these arrhythmias have changed little until 
recently. The past several years have seen an explosion of information 
regarding the mechanisms and management of these important 
arrhythmias. Practical details in patient management will be empha•
sized. A faculty discussion with participant interaction through a 
question and answer session will be an important part of the program. 
2:00 Mechanisms of Atrial Fibrillation and Atrial Flutter•
Implications for Catheter Ablative Therapy-Albert L. 
Waldo, M.D., FACC, Univ. Hosps. of Cleveland, OH 
2:30 Epidemiology of Atrial Fibrillation and Atrial Flutter•
Implications of the Framingham Heart Study and Other 
Clinical Studies-*Philip A. Wolf, M.D., Boston Univ. Sch. of 
Med., Boston, MA 
3:00 Prevention of Stroke in Atrial Fibrillation and Atrial 
Flutter Patients-Implications of the Recent Clinical 
Trials (SPAF I, BAATAF, AFASAK, CAFA, SPINAF, SPAF 
/I)-*Daniel E. Singer, M.D., Harvard Univ. Med. Sch., 
Boston, MA 
3:30 Break 
3:45 Antiarrhythmic Drug Therapy to Prevent or Suppress 
Atrial Fibrillation and Atrial Flutter-Efficacy and 
Safety-*Eric N. Prystowsky, M.D., FACC, Northside 
Card., Indianapolis, IN 
4: 15 Management of Ventricular Rate Control in Patients 
With Atrial Fibrillation and Atrial Flutter-Drug 
Therapy (Acute and Chronic); HIS Bundle Ablation•
Melvin M. Scheinman, M.D., FACe., Univ. of CA-San 
Francisco, San Francisco, CA 
4:45 Discussion 
Be sure to check the 
Final Program for all location and 
program updates. 
viii PROGRAM 
Issues in Cardiovascular Disease in the 
Elderly: Emphasis on Safety and 
Cost-Effectiveness _ loooj 
Sunday, March 13, 1994,2:00 p.m.-5:00 p.m. 
Georgia World Congress Center 
Chairman: Bernard J. Gersh, M.B., Ch.B., D.Phil., FACe., 
Georgetown Univ. Med. Ctr., Washington, DC 
The aging of our population has a major impact upon the socio•
economics of health care, the utilization of procedures, their safety, 
indications, and cost-effectiveness. This Mini-Course will provide an 
understanding of: 
the normal physiology of aging and its interaction with therapeutic 
agents. 
the magnitude of the issue of an aging population and the socio•
economic consequences. 
the management of myocardial infarction in the elderly with 
particular reference to the risks and benefits of thrombolytic therapy 
in primary angioplasty. 
the indications, contra indications, and outcomes of coronary bypass 
surgery in the elderly. 
the role of primary angioplasty and new devices in the management 
of angina pectoris in the elderly. 
2 :00 The Normal Physiology of the Aging Cardiovascular 
System and Its Impact Upon Treatment-Dalane W. 
Kitzman, M.D., FACe., Bowman Gray Sch. of Med., Winston•
Salem, NC 
2:30 Coronary Heart Disease in the Elderly: The Magnitude of 
the Problem and Socio-Economic Consequences-Bernard J. 
Gersh, M.B., Ch.B., D.Phil., FACe., Georgetown Univ. Med. 
Ctr., Washington, DC 
3:00 The Management of Acute Myocardial Infarction in the 
Elderly-David O. Williams, M.D., FACC, The RI Hosp., 
Providence, RI 
3:25 Break 
3:45 Coronary Bypass Surgery in the Elderly: Indications, 
Contradictions, and Long-Term Results-Bruce Whitney 
Lytle, M.D., FACC, Cleveland Clin. Fdn., Cleveland, OH 
4:10 PTCA in the Elderly-David R. Holmes, Jr., M.D., FACe., 
Mayo Clin., Rochester, MN 
4:35 Discussion 
403 
20th Annual Symposium for 
Directors of Adult Cardiology 
Training Programs 
Sunday, March 13, 1994, 2:00 p.m.-5:00 p.m. 
Georgia World Congress Center, 369W 
Chairman: Joseph S. Alpert, M.D., FACC, Univ. of AZ 
Hlth. Sci. Ctr., Tuscon, AZ 
Co-Chairman: David B. Pryor, M.D., FACC, Duke Univ. Med. 
Ctr., Durham, NC 
Outcomes Research-Change in Practice of Cardiology 
~ 1stAnnuai Report ofthe ACC National ~ Clinical Database Library 
404 
Sunday, March 13, 1994, 5:00 p.m.-5:30 p.m. 
Georgia World Congress Center 
Chairman: David P. Carmichael, M.D., FACC, Scripps Mem. 
Hosp., La Jolla, CA 
, + See disclosure statement 
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1:1 Catheter Ablationfor Supraventricular 
Iml Arrhythmias loooj 
501 
Sunday, March 13, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 265W 
Chairman: 'David E. Haines, M.D., FACC, Univ. of VA Hlth Sci. 
Ctr., Charlottesville, VA 
Participants: Karen J. Beckman, M.D., FACe., Univ. of OK, Oklahoma 
City, OK 
'Jonathan J. Langberg, M.D., FACe., Emory Univ. 
Hosp., Atlanta, GA 
Cynthia M. Tracy, M.D., FACC, Georgetown Univ. 
Med. Ctr., Washington, DC 
1:1 The Role of I notropic Therapy and New 
Iml Vasodilators in Congestive Heart Failure 
502 
Sunday, March 13, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 365W 
Chairman: 'Barry M. Massie, M.D., FACe., Univ. of CA-San 
Francisco, San Francisco, CA 
Participants: Michael R. Bristow, M.D., Ph.D., FACC, Univ. of CO 
Hlth. Sci. Ctr., Denver, CO 
Leslie W. Miller, M.D., FACe., St. Louis Univ. Med. Ctr., 
St. Louis, MO 
+Lynne Warner Stevenson, M.D., FACC, Brigham & 
Women's Hosp., Boston, MA 
1:1 Non-Invasive Assessment of Myocardial 
Iml Viability ~ 
503 ~ 
Sunday, March 13, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 260W 
Chairman: K. Lance Gould, M.D., FACC, Univ. of TX Med. Sch., 
Houston, TX 
Participants: Jeffrey Allen Leppo, M.D., FACC, Univ. of MA Med. 
Ctr., Worcester, MA 
'Thomas Ryan, M.D., FACe., IN Univ., Indianapolis, IN 
Mary N. Walsh, M.D., FACC, Northside Card., 
Indianapolis, IN 
B Hypertension 
504 
Sunday, March 13, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 254W 
Chairman: Michael A. Weber, M.D., FACC, VA Hosp., 
Long Beach, CA 
Participants: Edward D. Frolich, M.D., FACe., Ochsner Clin., 
New Orleans, LA 
Norman Kaplan, M.D., Univ of TX Hlth. Sci. Ctr., 
Dallas, TX 
'Franz H. Messerli, M.D., FACC, Ochsner Clin., 
New Orleans, LA 
CMf Credits 
Look for the CME Credit Statement 
for Registration Records in the 
Final Program. 
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Marfan Syndrome/Hypertrophic 
1:1 Cardiomyopathy-Clinical Molecular 
Imllnterface 
505 
Sunday, March 13, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 362W 
Chairman: *Reed E. Pyeritz, M.D., Ph.D., Allegheny-Singer Res. 
Inst., Pittsburgh, PA 
Participants: Richard B. Devereux, M.D., FACe., Cornell Med. 
Hosp., New York, NY 
Harry C Dietz, III, M.D., Johns Hopkins Univ. Sch. of 
Med., Baltimore, MD 
Ketty Schwartz, M.D., Hosp. Lariboisiere, Paris, FRANCE 
1:1 Pulmonary Hypertension-Advances in 
Iml Treatment 110 0 01 
506 
Sunday, March 13, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 256W 
Chairman: Joseph Loscalzo, M.D., Ph.D., FACC, Brigham & 
Women's Hosp., Boston, MA 
Participants: *Robyn J. Barst, M.D., FACe., Columbia Univ., New 
York, NY 
8 
507 
Barbara Cockrill, M.D., MA Gen. Hosp., Boston, MA 
*Stuart Rich, M.D., FACe., Univ. of IL, Chicago, IL 
Echocardiography in the Assessment of 
Patients With Coronary Artery Disease 
11
000
1 
Sunday, March 13, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 360W 
Chairman: *Paul G. Yock, M.D., FACe., Univ. of CA-San 
Francisco, San Francisco, CA 
Participants: Pamela S. Douglas, M.D., FACe., Beth Israel Hosp., 
Boston, MA 
B 
508 
Andre Keren, M.D., FACe., Birkur Cholim Hosp., 
Jerusalem, ISRAEL 
Thomas Marwick, M.D., Cleveland Clin. Fdn., Cleveland, 
OH 
Prognostication After Acute Myocardial 
Infarction in the Thrombolytic Era 1000 1 
Sunday, March 13, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 364W 
Chairman: *Kim A. Eagle, M.D., FACe., MA Gen. Hosp., Boston, 
MA 
Participants: Lawrence W. Gimple, M.D., FACC, Univ. of VA, 
Charlottesville, VA 
*Mario S. Verani, M.D., FACe., Baylor Clg. of Med., 
Houston, TX 
Donald A. Weiner, M.D., FACe., Boston Univ. Med. 
Ctr., Boston, MA 
* + See disclosure statement 
8 Evaluation of Syncope 
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Sunday, March 13, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 264W 
PROGRAM 
Chairman: Masood Akhtar, M.D., FACe., Mt. Sinai Med. Ctr., 
Milwaukee, WI 
ix 
Participants: NA Mark Estes, III, M.D., FACe., Weston, MA 
Richard I. Fogel, M.D., Northside Card., Indianapolis, IN 
Jasbir S. Sra, M.D., FACe., Sinai Samaritan Med. Ctr., 
Milwaukee, WI 
1:1 Cardiovascular Medicine in the Era of 
Iml Health Care Reform 10001 
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Sunday, March 13, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 363W 
Chairman: Michael J. Wolk, M.D., FACe., New York, NY 
Participants: Adolph M. Hutter, Jr., M.D., FACe., MA Gen. Hosp., 
Boston, MA 
William J. Marshall, M.D., FACe., Dayton, OH 
Marie Michnich, Dr.P.H., Amer. Clg. of Card., Bethesda, 
MD 
Plan to Attend! 
ACC '95 
·MARCH 19-23· 
BlgW @IIILi1A~1 
March 24-28, 1996 
Orlando, Florida 
March 16-20, 1997 
Anaheim, California 
March 29-April 2, 1998 
Atlanta, Georgia 
March 7-11,1999 
New Orleans, Louisiana 
March 12-16, 2000 
Anaheim, California 
March 18-22, 2001 
Orlando, Florida 
x PROGRAM 
Jogging/Walking Event 
6:30a.m. Rain or shine. Enjoy a cool-down continental 
breakfast at the conclusion of the event. 
The jogging/walking event is sponsored by a 
grant from Lederle Laboratories and Advantus 
Pharmaceuticals. 
Registration 
Monday, March 14, 1994,7:30 a.m.-5:00 p.m. 
Georgia World Congress Center, Hall E 
Opening Plenary Session 
405 
Monday, March 14, 1994,8:45 a.m.-10:00 a.m. 
Georgia World Congress Center, Ballroom 
Chairman: Sylvan Lee Weinberg, M.D., FACe., Dayton, OH 
Opening Plenary Session/Simon Dack Lecture* 
Peering Into the Future of Cardiac PharmacologY-Sir James 
Black, F.R.S., F.R.CP., Rayne Inst., London, UNITED KINGDOM 
*The Simon Dack Lecture is supported by the Simon and 
Jacqueline Dack Endowment Fund. 
Exposition 
Monday, March 14, 1994,9:00 a.m.-S:OO p.m. 
Georgia World Congress Center, Halls D-H 
The Exposition offers you the opportunity to obtain first-hand 
the latest information on pharmaceutical products, equipment, 
medical devices, and other services. With nearly 400 compa•
nies, you maximize your time, and still have the opportunity 
for one-on-one exchange with knowledgeable industry 
representatives. Exhibit product searches are available for the 
first time at ACC'94. Obtain a customized search by using your 
Expocard at the centrally located computer terminals. Users 
select the category(ies) of interest, then read or print a list of 
exhibitors offering the product/service. 
Exhibit product and education searches 
are available for the first time at A CC'94! 
Obtain customized program planners by 
using your Expocard at the centrally 
located computer terminals. 
* + See disclosure statement 
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Clinical Decision Making 
406 
Monday, March 14, 1994, 10:30 a.m.-Noon 
Georgia World Congress ("",tor. Ballroom 
Co-Chairmen: Suzanne B. Knoebel, M.D., FACe., Krannert Inst. 
of Card., Indianapolis, IN 
Eric S. Williams, M.D., FACC, Krannert Inst. of 
Card., Indianapolis, IN 
Case discussion includes: patients who had problems of 
prosthetic aortic valve with a high echo gradient and possible 
presyncope; new onset atrial fibrillation; management in the 
emergency room of unstable angina versus myocardial 
infarction; use of urokinase for thrombus in recent vein grafts; 
congestive heart failure with electrocardiographic infarct 
pattern in the presence of normal coronary arteries and 
possible vasospasm; severe peripheral vascular disease and its 
preoperative evaluation for bifemoral grafting; and thrombus 
in a single right coronary lesion in a young man with 
hypercholesterolemia. 
Participants: Bruce H. Brundage, M.D., FACC, Harbor UCLA 
Med. Ctr., Torrance, CA 
Lawrence H. Cohn, M.D., FACC, Brigham & 
Women's Hosp., Boston, MA 
Cindy L. Grines, M.D., FACe., William Beaumont 
Hosp., Royal Oak, MI 
Melvin M. Scheinman, M.D., FACC, Univ. of 
CA-San Fransisco, San Fransisco, CA 
Arthur E. Weyman, M.D., FACe., MA Gen. 
Hosp., Boston, MA 
C Young Investigators Awards Competition 
407 
Monday, March 14, 1994, 10:30 a.m.-Noon 
Georgia World Congress Center, 362W 
Chairman: Douglas P. Zipes, M.D., FACC, Krannert Inst. of 
Card., Indianapolis, IN 
Judges: Mark L. Entman, M.D., FACC, Baylor Clg. of Med., 
Houston, TX 
David R. Hathaway, M.D., FACe., Krannert Inst. of 
Card., Indianapolis, IN 
Marc D. Thames, M.D., FACC, Univ. Hosp. of 
Cleveland, Cleveland, OH 
R. Sanders Williams, M.D., FACC, Univ. ofTX, 
Southwestern Med. Ctr., Dallas, TX 
The ACC Young Investigators Awards Competition is supported by a 
grant from Searle. 
JACC February 1994:ii-xxx 
~ Molecular Biology for the Clinician 
650 
Monday, March 14, 1994, 10:30 a.m.-Noon 
Georgia World Congress Center, 265W 
Chairman: Morton F. Arnsdorf, M.D., FAe.e., Univ. of Chicago 
Hosp., Chicago, IL 
10:30 Gene Mapping in Cardiovascular Disorders-G. Michael 
Vincent, M.D., FAe.e., Univ. of UT Sch. of Med., Salt Lake 
City, UT 
11 :00 The Importance of Myocardial Growth Factors-Thomas 
Brand, Ph.D., Baylor Clg. of Med., Houston, TX 
11 :30 The Future of Gene Therapy in Cardiology-* Jeffrey 
Lelden, M.D., Ph.D., Univ. of Chicago, Chicago, IL 
601 
ECG Differential Diagnosis of Cardiac 
Arrhythmias: Lessons From Clinical 
Electrophysiology 
Monday, March 14, 1994, 10:30 a.m.-Noon 
Georgia World Congress Center, Auditorium 
Co-Chairmen: Mark E. Josephson, M.D., FAe.e., Beth Israel Hosp., 
Boston, MA 
Eric N. Prystowsky, M.D., FAe.e., Northside Cardiol., 
P.e., Indianapolis, IN 
10:30 An Overview of Mechanisms of Supraventricular 
Tachyarrhythmias-Hein J. J. Wellens, M.D., FAe.e., Acad. 
Hosp. Maastricht, Maastricht, THE NETHERLANDS 
10:45 Supraventricular Tachycardia: Diagnosis of Atrioven•
tricular Node Dependent and Independent Mecha•
nisms-Eric N. Prystowsky, M.D., FAe.e., Northside 
Cardiol., P.e., Indianapolis, IN 
11 :00 Mechanism of Wide QRS Complex Tachycardia-John J. 
Gallagher, M.D., FAe.e., The Sanger Clin., P.A., Charlotte, NC 
11: 15 Wide QRS Tachycardia-Supraventricular vs. Ventricular 
by Electrocardiography-Ma rk E. Josephson, M.D., FAe.e., 
Beth Israel Hosp., Boston, MA 
11 :30 Diagnostic Use of Drugs and Maneuvers to Differentiate 
Arrhythmias-A. John Camm, MD, FAe.e., st. George's 
Hosp. Med. Sch., London, UNITED KINGDOM 
11 :45 VentricularProarrhythmia: Torsadede Pointes-Philippe 
Coumel, M.D., Hosp. Lariboisiere, Paris, FRANCE 
rmn The Cardiovascular Physician and Health .1 Care Reform 1994 
602 
Monday, March 14, 1994, 10:30 a.m.-Noon 
Georgia World Congress Center, 361W 
See the Final Program for session updates. 
Visit the ACC'94 Exposition for a 
complete update on cardiovascular 
services and products. 
* + See disclosure statement 
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When Should Atherectomy, Lasers, and 
Stents Be Used, and What Evidence Is 
JW1 There That Outcome Is Different 
••• Compared to Conventional Angioplasty? 
201 _ loco) 
Monday, March 14, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 216E 
Co-Chairmen: *Gary S. Roubin, M.D., Ph.D., FAe.e., Univ. of AL, 
Birmingham, AL 
Patrick W. Serruys, M.D., FAe.e., Erasmus Univ., 
Rotterdam, THE NETHERLANDS 
III Management of Arrhythmias in Children 
202 
Monday, March 14, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 219E 
Co-Chairmen: Barbara J. Deal, M.D., FAe.e., Children's Memorial 
Hosp., Chicago, IL 
Ann Dunnigan, M.D., FAe.e., Univ. of MN, 
Minneapolis, MN 
III 
How Does Coronary Patency Correspond 
to Survival After M I? I nsights From the 
GUSTO and LATE Trials _ loco) 
203 
Monday, March 14, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 204E 
Co-Chairmen: *Paul Wayne Armstrong, M.D., FAe.e., Univ. of 
Alberta, Edmonton, CANADA 
*Allan M. Ross, M.D., FAe.e., George Washington 
Univ. Med. Ctr., Washington, DC 
III Quantitative EchocardiographyjDoppler 
204 
Monday, March 14, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 217E 
Co-Chairmen: Navin e. Nanda, M.D., FAe.e., Univ. of AL, 
Birmingham, AL 
J.R.T.e. Roelandt, M.D., FAe.e., Erasmus Univ., 
Rotterdam, THE NETHERLANDS 
rW1 Radionuclide Detection of Myocardial 
••• Viability-Conventional Imaging vs. PET 
205 
Monday, March 14, 1994, 10:30 a.m.-11:30 a.m. 
Georgia World Congress Center, 203E 
Co-Chairmen: Jeffrey Allen Leppo, M.D., FAe.e., Univ. of MA Med. 
Ctr., Worcester, MA 
Heinrich R. Schelbert, M.D., Ph.D, FAe.e., Univ. of CA 
Sch. of Med., Los Angeles, CA 
xii PROGRAM 
Estrogen Replacement in Post-Menopausal 
Women for Primary and Secondary 
rw1 Prevention of Coronary Artery Disease 
••• Sequelae _ 10001 
206 
Monday, March 14, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 218E 
Co-Chairmen: Elizabeth Barrett-Connor, M.D.,Univ. of CA-San Diego, 
San Diego, CA 
301 
'Charles E. Rackley, M.D., FACe., Georgetown Univ. 
Hosp., Washington, DC 
Intracoronary Stents-Who, When, and 
Where _ 10001 
Monday, March 14, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: 'Richard S. Stack, M.D., FACC, Duke Univ. Med. 
Ctr., Durham, NC 
Participants: Larry S. Dean, M.D., FACC, Univ. of AL at Birmingham, 
Birmingham, AL 
302 
'Neal L. Eigler, M.D., FACC, Cedars-Sinai Med. Ctr., 
Los Angeles, CA 
Paul Tierstein, M.D., FACe., Scripps Clin. & Res. Fdn., La 
Jolla,CA 
Management of Hypertrophic 
Cardiomyopathy in Children 
Monday, March 14, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: James H. Moller, M.D., FACe., Univ. of MN, 
Minneapolis, MN 
Participants: Lameh Fananapazir, M.D., Natl. Inst. of Hlth., Bethesda, 
MD 
Robert H. Feldt, M.D, FACC, Mayo Clin, Rochester, 
MN 
Jeffrey Towbin, M.D., Baylor Clg. of Med., Houston, TX 
Pharmacologic Therapies of Coronary 
111ft Artery Disease: Lessons Learned From 
r--j Clinical Trials _ 10001 
303 
Monday, March 14, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: Gottlieb C Friesinger, II, M.D., FACC, Vanderbilt 
Med. Ctr., Nashville, TN 
Participants: C Richard Conti, M.D., FACC, Univ. of FL, Gainsville, FL 
'Michael B. Fowler, M.B., FACC, Stanford Univ. Med. 
Ctr., Stanford, CA 
Gregory L. Freeman, M.D., FACC, Univ. ofTX Hlth. Sci. 
Ctr., San Antonio, TX 
, + See disclosure statement 
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111ft Exercise Echo and Perfusion Scintigraphy-
r--j Which Is Best? _ 10001 
304 
Monday, March 14, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: Julius M. Gardin, M.D., FACC, Univ. of CA, Irvine, CA 
Participants: Timothy M. Bateman, M.D., FACC, Mid-America 
r"J 
305 
Heart Inst., Kansas City, MO 
George A. Beller, M.D., FACC, Univ. of VA, 
Charlottesville, VA 
'Thomas Ryan, M.D., FACC, IN Univ., Indianapolis, IN 
Innovations/New Technologies in 
Implantable Defibrillators _ 10001 
Monday, March 15, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: Seymour Furman, M.D., FACC, Montefiore Hosp. & 
Med. Ctr., Bronx, NY 
Participants: Alan D. Bernstein, Eng.Sc.D., FACC, Newark Beth Israel 
Med. Ctr., Newark, NJ 
'Jerry C Griffin, M.D., FACC, Univ. of CA, San 
Francisco, CA 
Raymond Yee, M.D., FACC, Univ. Hosp., London, 
CANADA 
TIMIII Revisited: Who Should Have Early 
111ft Cardiac Catheterization Following 
r--j ThrombolyticTherapy? _ ~ 
~ 306 
Monday, March 15, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: Hiltrud S. Mueller, M.D., FACC, Montefiore Hosp. & 
Med. Ctr., Bronx, NY 
Participants: Frederick Feit, M.D., FACC, NY Univ. Sch. of Med., New 
York, NY 
+William J. Rogers, M.D., FACC, Univ. of AL, 
Birmingham, AL 
David o. Williams, M.D., FACe., The RI Hosp., 
Providence, RI 
r"J Cardiogenic Shock: Therapeutic Options 
307 .10001 
Monday, March 15, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: Willard M. Daggett, M.D., FACC, MA Gen. Hosp., 
Boston, MA 
Participants: Michael J. Domanski, M.D., FACC, Natl. Heart, Lung, 
& Blood Inst., Bethesda, MD 
JamesA. Goldstein, M.D., FACe., Washington Univ., st. 
Louis, MO 
Walter E. Pae, Jr., M.D., FACC, The PA State Univ., 
Hershey, PA 
Be sure to check the 
Final Program for aI/location and 
program updates. 
JACC February 1994:ii-xxx 
111ft Why Can't Patients With Heart Failure 
r--J Exercise? _ joool 
308 
Monday, March 15, 1994, Noon-1 :45 p.m. 
Georgia World Congress Center 
Chairman: Thierry LeJemtel, M.D., Albert Einstein Clg. of Med., 
Bronx, NY 
Participants: Donna Mancini, M.D., Columbia Presbyterian Med. 
etr., New York, NY 
John Minotti, M.D., Univ. of CA--San Francisco, San 
Francisco, CA 
John R. Wilson, M.D., FACC, Vanderbilt Univ. Med. 
etr., Nashville, TN 
The Medical Management of Patients With 
Probable AMI Priorto Hospitalization: 
111ft Aspirin, Heparin, Magnesium, Lidocaine, 
l- --J Thrombolytic Therapy 
309 _ 10001 
Monday, March 15, 1994, Noon-1 :45 p.m. 
Georgia World Congress Center, Levels 2 and 3 
Chairman: J. Ward Kennedy, M.D., FACC, Univ. of WA Sch. of 
Med., Seattle, WA 
Participants: Mervin S. Gottsman, M.D., FACC, Hadassah Univ. 
Hosp., Jerusalem, ISRAEL 
Allan S. Jaffe, M.D., FACC, Washington Univ. Sch. 
of Med., St. Louis, MO 
W. Douglas Weaver, M.D., FACe., Univ. of WA, 
Seattle, WA 
111ft Who Is and Who Isn't a Candidate for l- -.. j Heart Transplant? 
310 _10001 
Monday, March 15, 1994, Noon-1:45 p.m. 
Georgia World Congress Center, Levels 2 and 3 
Chairman: Maria Rosa Costanzo, M.D., FACC, Loyola Univ. 
Med. etr., Maywood, IL 
Participants: G. William Dec, Jr., M.D., FACC, MA Gen. Hosp., 
Boston, MA 
Douglas Ensley, M.D., St. Francis Hosp., Tulsa, OK 
Sara J. Shumway, M.D., FACe., Univ. of MN, 
Minneapolis, MN 
~ Role of Endogenous Mediators in the Development and Progression of Cardiovascular Diseases 
651 10001 
Monday, March 14, 1994,2:00 p.m.-S:30 p.m. 
Georgia World Congress Center, 265W 
Co-Chairmen: Francis J. Klocke, M.D., FACC, Northwestern Sch. of 
Med., Chicago, IL 
James T. Willerson, M.D., FACC, Univ. of TX Med. 
Sch., Houston, TX 
2:00 Nitric Oxide-Thomas W. Smith, M.D., FACC, Brigham & 
Women's Hosp., Boston, MA 
2:30 Cytokines-Peter Libby, M.D., FACC, Brigham & Women's 
Hosp., Boston, MA 
3:00 Natriuretic Pep tides and Endothelin-John Burnett, M.D., 
Mayo Clin., Rochester, MN 
3:30 Break 
* + See disclosure statement 
PROGRAM 
4:00 Angiotensin /I-Robert Wayne Alexander, M.D., Ph.D., 
FACe., Emory Univ., Atlanta, GA 
xiii 
4:30 Norepinephrine-George Cooper, IV, M.D., VA Med. etr., 
Charleston, SC 
5:00 Prostaglandins-* James H. Chesebro, M.D., FACC, MA 
Gen. Hosp., Boston, MA 
~ Clinical Trials in Congestive Heart Failure 
603 10001 
Monday, March 14, 1994, 2:00 p.m.-3:30 p.m. 
Georgia World Congress Center, Ballroom 
Co-Chairmen: Kanu Chatterjee, M.D., FACC, San Francisco, CA 
Carl V. Leier, M.D., FACC, OH State Univ. Hosps., 
Columbus,OH 
2:00 Prospective Randomized Flosequinan Longevity 
Evaluation (PROFILE) Study: Background and Study 
Design-*Karl B. Swedberg, M.D., FACC, Goteberg, 
SWEDEN 
2: 15 PROFILE Study: Main Results-*Milton Packer, M.D., 
FACC, Columbia Univ., New York, NY 
2: 3 5 PROFILE Study: Ancillary Trial and Substudy Results-Jea n 
L. Rouleau, M.D., FACC, Inst. de Card. de Montreal, 
Montreal, CANADA 
2:45 Flolan International Randomized Survival Trial Study 
(FIRST): Background and Study Design-*Mihai 
Gheorghiade, M.D., FACC, Northwestern Univ. Med. Sch., 
Chicago, IL 
2:55 FIRST Study_- Main Results-*Robert M. Califf, MD, 
F.A.Ce., Duke Univ. Med. etr., Durham, NC 
3: 15 What the PROFILE and FIRST Studies Teach Us-* Barry M. 
Massie, M.D., FACe., Univ. of CA-San Francisco, San 
Francisco, CA 
f"'n Late Results After Repair of Tetralogy of .1 Fallot-Fate ofthe Dilated Right Ventricle 
604 10001 
Monday, March 14, 1994,2:00 p.m.-330 p.m. 
Georgia World Congress Center, 363W 
Co-Chairmen: Gordon K. Danielson, M.D., FACC, Mayo Med. Sch.j 
Fdn., Rochester, MN 
Thomas P. Graham, Jr., M.D., FACC, Vanderbilt Med. 
etr., Nashville, TN 
2:00 Evaluation of Right Ventricular Function-Thomas P. 
Graham, Jr., M.D., FACC, Vanderbilt Med. etr., Nashville, TN 
2:20 Technical Evaluation of the Procedure-Albert D. Pacifico, 
M.D., FACC, Univ. of AL, Birmingham, AL 
2:40 Long-Term Fo/low-Up-Robert H. Feldt, M.D., FACC, 
Mayo Clin., Rochester, MN 
3:00 Re-Operation-Indications and Techniques-Gordon K. 
Danielson, M.D., FACC, Mayo Med. Sch./Fdn., Rochester, 
MN 
CMf Credits 
Look for the CME Credit Statement 
for Registration Records in the 
Final Program. 
xiv 
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Joint Symposium: European 
Society of Cardiology/American 
College of Cardiology 
Monday, March 14, 1994,2:00 p.m.-5:30 p.m. 
Georgia World Congress Center, Auditorium 
Sudden Cardiac Death, Part I 
Co-Chairmen: Sylvan Lee Weinberg, M.D., FACC, Good 
Samaritan Hosp., Dayton, OH 
Michel E. Bertrand, M.D., FACC, Hosp. Cardiol., 
Lille, FRANCE 
2:00 Basic Mechanisms of Sudden Cardiac Death•
Douglas P. Zipes, M.D., FACC, IN Univ. Sch. of Med., 
Indianapolis, IN 
2 :30 Evaluation of Patients With Sudden Cardiac 
Death-A. John Camm, M.D., FACC, St. George's 
Hosp. Med. Sch., London, UNITED KINGDOM 
3 :00 The Pharmacologic Management of Ventricular 
Arrhythmias in Patients With Sudden Cardiac 
Death-Raymond L. Woosley, M.D., Ph.D., FACC, 
Georgetown Univ. Med. Sch., Washington, DC 
3:30 Intermission 
Sudden Cardiac Death, Part 1/ 
Co-Chairmen: Richard O. Russell, Jr., M.D., FACC, 
Cardiovascular Assoc., Inc., Birmingham, AL 
Sigurd Nitter-Hauge, M.D., Ph.D., Rikshopitalet, 
Oslo, NORWAY 
4:00 The Evaluation and Management of Patients With 
Sudden Cardiac Death Related to the Long QT 
Syndrome-Peter J. Schwartz, M.D., FACC, Univ. 
of Pavia, Pavia, ITALY 
4:30 The Evaluation and Management of Patients 
With Sudden Cardiac Death Related to Hyper•
trophic Cardiomyopathy-Lameh Fananapazir, 
M.D., Nat. Inst. of Hlth., Bethesda, MD 
5:00 The Aggressive Management of Patients With 
Ventricular Tachyarrhythmias: Ablation, Surgery, 
and Implantable Defibrillators-Gunter Breithardt, 
M.D., FACC, Univ. Munster, Munster, GERMANY 
JW1 The Role of Rescue Angioplasty in the 
••• ManagementofAMI _ 10Doj 
207 
Monday, March 14, 1994,2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 203E 
Co-Chairmen: Stephen G. Ellis, M.D., FACC, Cleveland Clin. Fdn., 
Cleveland,OH 
fII 
208 
William P. Hood, Jr., M.D., FACC, Dothan, AL 
Howto Detect and Manage Diastolic 
Dysfunction in Patients With Heart Failure 
-~ Monday, March 14, 1994,2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 219E 
Co-Chairmen: Rick A. Nishimura, M.D., FACC, Mayo Clin., 
Rochester, MN 
James F. Spann, Jr., M.D., FACC, Med. Univ. of SC, 
Charleston, SC 
* + See disclosure statement 
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fII 
Controlled Clinical Trials in Cardiology: 
Costs, Ethics, and Proven Impact on 
Clinical Practice _ locoj 
209 
Monday, March 14, 1994,2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 218E 
Co-Chairmen: Curt Furberg, M.D., Bowman Gray Sch. of Med., 
Winston-Salem, NC 
Eugene R. Passamani, M.D., FACC, Washington, DC 
III Heart Disease in Women 
210 
Monday, March 14, 1994,2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 217E 
Co-Chairmen: Jeffrey L. Probstfield, M.D., FACC, Fred Hutchinson 
Cancer Res. Ctr., Seattle, WA 
*Nanette Kass Wenger, M.D., FACC, Emory Univ. Sch. 
of Med., Atlanta, GA 
III Three-Dimensional Echocardiography 
211 _ 10Doj 
Monday, March 14, 1994,2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 216E 
Co-Chairmen: *Donald King, M.D., Columbia Univ., New York, NY 
Natesa G. Pandian, M.D., FACC, Tufts Univ., Boston, 
MA 
III Artificial Heart Valves: What Is "Optimal" in 1994? _ ~ 
212 ~ 
Monday, March 14, 1994,2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 204E 
Co-Chairmen: Walter Randolph Chitwood, Jr., M.D., F.A.C.C., East 
Carolina Univ., Greenville, NC 
408 
John J. Collins, Jr., M.D., FACC, Brigham & Women's 
Hosp., Boston, MA 
Bethesda Conference Reports 
Monday, March 14, 1994,4:00 p.m.- 6:00 p.m. 
Georgia World Congress Center, 264W 
Part I: 25th Annual Bethesda Conference Report 
Co-Chairmen: Rolf M. Gunnar, M.D., FACC, Riverside, IL 
Roberta G. Williams, M.D., FACC, UCLA 
Med. Ctr., Los Angeles, CA 
4:00 Future Personnel Needs in Cardiovascular Health 
Care 
Part 1/: 26th Annual Bethesda Conference Report 
Co-Chairmen: Barry J. Maron, M.D., FACC, Minneapolis 
Heart Inst. Fdn., Minneapolis, MN 
Jere H. Mitchell, M.D., FACC, Univ. ofTX 
Southwestern Med. Ctr., Dallas, TX 
5:00 Standards for Determining Eligibility for 
Competition in Athletes With Cardiovascular 
Abnormalities 
lACC February 1994:ii-xxx 
Implications of Recent Multicenter Trials rmn for Treatment of Patients With Chronic .1 Heart Failure ioooj 
606 
Monday, March 14, 1994, 4:00 p.m.-5:30 p.m. 
Georgia World Congress Center, Ballroom 
Co-Chairmen Jay N. Cohn, M.D., FACe, Univ. of MN Med. Sch, 
Minneapolis, MN 
William W. Parmley, M.D., FACC, Moffitt Hosp., San 
Francisco, CA 
4:00 Digitalis-Thomas W. Smith, M.D., FACe, Brigham & 
Women's Hosp., Boston, MA 
4:15 New Vasodilator Drugs-* Milton Packer, M.D., FACe, 
Columbia Clg. of Phys. & Surg., New York, NY 
4:30 New Positive Inotropic Drugs-* Arthur M. Feldman, MD, 
Ph.D., FACe, Johns Hopkins Sch. of Med, Baltimore, MD 
445 Beta-Adrenergic Blockers-Finn Waagstein, M.D, Wallenberg 
Lab, Goteburg, SWEDEN 
5:00 Anti-ArrhythmicDrugs-Ronald Campbell, M.D., Freeman 
Hosp., Newcastle-Upon-Tyne, UNITED KINGDOM 
rw1 Quantitative Coronary Angiography-Will 
••• It Become "Standard Practice"? __ ~ 
213 .... ~ 
Monday, March 14, 1994, 4:00 p.m.-5:00 p.m. 
Georgia World Congress Center, 216E 
Co-Chairmen: J. Larry Klein, M.D., FACe, Grady Mem. Hosp., 
Atlanta, GA 
*Robert A. Vogel, M.D., FACe, Univ. of MD Hosp., 
Baltimore, MD 
rw1 Management of Cardiac Tamponade by 
••• Percutaneous Balloon Pericardiotomy 
214 
Monday, March 14, 1994, 4:00 p.m.-5:00 p.m. 
Georgia World Congress Center, 217E 
Co-Chairmen: Peter C Block, M.D., FACe, St. Vincent Heart Inst., 
Portland, OR 
* Andrew A. Ziskind, MD, FACe, Univ. of MD Hosp., 
Baltimore, MD 
The American College of Cardiology 
promotes a "No Smoking" policy_ The 
use of tobacco products is strictly 
prohibited in all areas of the Conven•
tion Center and all hotel meeting 
rooms hosting A CC events. 
Thank you for not smoking. 
* + See disclosure statement 
III 
215 
PROGRAM 
Detection of Prosthetic Valve 
Dysfunction 
xv 
Monday, March 14, 1994, 4:00 p.m.-S:OO p.m. 
Georgia World Congress Center, 219E 
Co-Chairmen: Michael H. Crawford, M.D., FACe, The Univ. of NM, 
Albuquerque, NM 
III 
216 
* Alan S. Pearlman, M.D., FACC, Univ. of WA, Seattle, 
WA 
The Potential for Gene Transfer I nto the 
Arterial Wall .. 
Monday, March 14, 1994, 4:00 p.m.-5:00 p.m. 
Georgia World Congress Center, 218E 
Co-Chairmen: David A Dichek, M.D., Nat!. Inst. of Hlth., Bethesda, 
MD 
III 
217 
* Jeffrey M. Isner, MD, FACe, St. Elizabeth Hosp., 
Boston, MA 
"Curing" Arrhythmias With Radiofrequency 
Ablation .. 
Monday, March 14, 1994, 4:00 p.m.-S:OO p.m. 
Georgia World Congress Center, 203E 
Co-Chairmen: *Warren M. Jackman, M.D., FACC, Univ. of OK Hlth. 
III 
218 
Sci. Ctr, Oklahoma City, OK 
G. Neal Kay, M.D., FACe, Univ. of AL, Birmingham, AL 
The Role of Magnesium in the Treatment 
of Acute Myocardial Infarction .. 10001 
Monday, March 14, 1994,4:00 p.m.-5:00 p.m. 
Georgia World Congress Center, 204E 
Co-Chairmen: Rory Collins, M.B.B.S, FACe, Oxford Univ., Oxford, 
UNITED KINGDOM 
K. L. Woods, M.D., Leicester Royal Infirm., Leicester City, 
UNITED KINGDOM 
10001 
Audio Tapes 
You will find a form to purchase audio tapes 
of selected ACC'94 sessions (including Meet 
the Experts) in the Final Program. 
xvi PROGRAM 
Jogging/Walking Event 
6:30a.m. Rain or shine. Enjoy a cool-down continental 
breakfast at the conclusion of the event. 
The jogging/walking event is sponsored by a 
grant from Lederle Laboratories and Advantus 
Pharmaceuticals. 
Registration 
Tuesday, March 15, 1994,8:00 a.m.-5:00 p.m. 
Georgia World Congress Center, Hall E 
Exposition 
Tuesday, March 15, 1994,9:00 a.m.-5:00 p.m. 
Georgia World Congress Center, Halls D-H 
The Exposition offers you the opportunity to obtain first-hand the 
latest information on pharmaceutical products, equipment, 
medical devices, and other services. With nearly 400 companies, 
you maximize your time, and still have the opportunity for one•
on-one exchange with knowledgeable industry representa•
tives. Exhibit product searches are available for the first time at 
ACC94. Obtain a customized search by using your Expocard 
at the centrally located computer terminals. Users select the 
category(ies) of interest, then read or print a list of exhibitors 
offering the product/service. 
~ Management of Cardiovascular Disorders: What Is the State-of-the-Art in the Mid-1990s? 
652 ioooj 
Tuesday, March 15, 1994, 8:30 a.m.-Noon 
Georgia World Congress Center, Auditorium 
Co-Chairmen: J. Willis Hurst, M.D., Emory Univ., Atlanta, GA 
J. Ward Kennedy, M.D., FACC, WA Univ. Sch. of 
Med., Seattle, WA 
8:30 How Should Physicians Manage Congestive Heart 
Failure?-William W. Parmley, M.D., FACC, Univ. of CA•
San Francisco, San Francisco, CA 
9:00 How Should Physicians Manage Unstable Angina?•
Pierre Theroux, M.D., FACC, Montreal, CANADA 
9:30 How Should Physicians Manage Supraventricular 
Arrhythmias?-*Edward L.C Pritchett, M.D., Duke Univ. Med. 
Ctr., Durham, NC 
10:00 Break 
10:30 How Should Physicians Manage Ventricular 
Arrhythmias?-A. John Camm, M.D., FACC, St. George's 
Hosp. Med. Sch., London, UNITED KINGDOM 
11 :00 How Should Physicians Manage Systolic and Diastolic 
Hypertension?-Michael A. Weber, M.D., FACC, VA 
Hosp., Long Beach, CA 
11 :30 How Should Physicians Manage an Acute Myocardial 
Infarction?-C Richard Conti, M.D., F.A.CA., Univ. of FL, 
Gainesville, FL 
* + See disclosure statement 
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~ Clinical Trials in Myocardial Ischemia 
607 
Tuesday, March 15, 1994,8:30 a.m.-1 0:00 a.m. 
Georgia World Congress Center, Ballroom 
Co-Chairmen: J.P. Bounhoure, M.D., French Soc. of Card., Paris, 
FRANCE 
Walter Somerville, M.D., FACC, London, UNITED 
KINGDOM 
8:30 Asymptomatic Cardiac Ischemia Pilot (ACIP)-C Richard 
Conti, M.D., FACC, Univ. of FL, Gainesville, FL 
8:43 Emory Angioplasty Surgery Trial (EAST)-Spencer B. 
King, III, M.D., FACC, Emory Univ. Hosp., Atlanta, GA 
8:56 Coronary Angioplasty vs. Bypass Revascularization 
Investigation (CABRI)-Michel E. Bertrand, M.D., FACC, 
Hosp. Cardio!., Lille, FRANCE 
9:09 New Guidelines for the Management of Unstable 
Angina-Eugene Braunwald, M.D., FACC, Brigham and 
Women's Hosp., Boston, MA 
9:21 German Angioplasty Bypass Investigation (GABI)•
Thomas A. Ischinger, M.D., FACC, Klinikum Bogenhausen, 
Munich, GERMANY 
9:34 Global Utilization of Streptokinase and t-PA for 
Occluded Arteries (GUSTO )-Eric J. Topol, M.D., FACC, 
The Cleveland Clin. Fdn., Cleveland, OH 
9:47 Randomized Intervention Treatment of Angina (RITA) 
~ Endocavitary Ablationfor Arrhythmias 
608 loooj 
Tuesday, March 15, 1994, 8:30 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 365W 
Co-Chairmen: John D. Fisher, M.D., FACC, Montefiore Hosp., 
Bronx, NY 
Guy Fontaine, M.D., Ph.D., FACC, Hosp. Jean Rostand, 
Ivry, FRANCE 
8:30 Ablation ofAtriaIArrhythmias-*David E. Haines, M.D., 
FACC, Univ. of VA Med. Ctr., Charlottesville, VA 
8:45 AV Nodal Re-Entry Tachycardia-*Warren M. Jackman, 
MD., FACC, Univ. of OK Hlth. Sci. Ctr., Oklahoma City, OK 
9:00 Wolff-Parkinson-WhiteSyndrome-Karl H. Kuck, M.D., 
FACC, Univ. Hosp. Eppendorf, Hamburg, GERMANY 
9:15 
9:30 
9:45 
Radiofrequency Ablation to Cure A trial Flutter and A trial 
Tachycardia-J. Marcus Wharton, M.D., Duke Univ. Med. Ctr., 
Durham, NC 
Radiofrequency Ablation to Cure Ventricular 
Tachycardia-*William M. Miles, M.D., FACe., Krannert 
Inst., Indianapolis, IN 
High Energy. Low Energy. and Radio Frequency: Which 
Form of Energy Under Which Circumstances?-Edward 
Rowland, M.D., FACC, St. George's Hosp. Med. Sch., 
London, UNITED KINGDOM 
JACC February 1994:ii-xxx 
Neurohormonal Hypothesis and the 
rw1 Pathophysiology of Congestive Heart 
••• Failure _ !oooj 
219 
Tuesday, March 15, 1994,9:00 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 219E 
Co-Chairmen: Stuart Katz, M.D., Columbia Presbyterian Hosp., New 
York, NY 
Gordon W. Moe, M.D., FACC, st. Michael's Hosp., 
Toronto, CANADA 
I'W1 Optimal Use of SPECT Perfusion Imaging 
••• for Detection of Coronary Artery Disease 
220 _ joooj 
Tuesday, March 15, 1994, 9:00 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 218E 
Co-Chairmen: James E. Udelson, M.D., FACC, Tufts Univ./New Eng. 
Med. Ctr., Boston, MA 
*Frans J. Th. Wackers, M.D., Ph.D., FACC, Yale Univ. 
Sch. of Med., New Haven, CT 
I'W1 Role of Trans esophageal Echo in Suspected 
••• CardiogenicStroke _ loooj 
221 
Tuesday, March 15, 1994, 9:00 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 216E 
Co-Chairmen: Navin C Nanda, M.D., FACe.. Univ. of AL, 
Birmingham, AL 
Nelson B. Schiller, M.D, FACe.. Univ. of CA-San 
Francisco, San Francisco, CA 
I'W1 Which Ventricular Arrhythmias Require 
••• Treatment? _ loooj 
222 
Tuesday, March 15, 1994, 9:00 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 203E 
Co-Chairmen: Masood Akhtar, M.D., FACe., Mt. Sinai Med. Ctr., 
Milwaukee, WI 
Robert J. Myerburg, M.D., FACC, Univ. of Miami Med. 
Ctr., Miami, FL 
I'W1 Percutaneous Valvulotomy: Update on 
••• Techniques and Long-Term Results 
223 _Ioooj 
Tuesday, March 15, 1994,9:00 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 204E 
Co-Chairmen: Larry S. Dean, M.D., FACC, Univ. of AL, Birmingham, 
AL 
Igor F. Palacios, M.D., FAe.e.. MA Gen. Hosp., 
Boston, MA 
* + See disclosure statement 
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111 Fetal Echocardiography 
224 
Tuesday, March 15, 1994,9:00 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 217E 
Co-Chairmen: Derek A. Fyfe, M.D, Ph.D., FACC, Med. Univ. of SC, 
Charleston, SC 
James C Huhta, M.D., FACC, Pennsylvania Hosp., 
Philadelphia, PA 
xvii 
rmn Restenosis in Coronary Artery Disease: 
.1 Trials and Prospects ijoooj 
609 
Tuesday, March 15, 1994, 10:30 a.m.-Noon 
Georgia World Congress Center, Ballroom 
Co-Chairmen: John Parker, M.D., St. George's Hosp. Med. Sch., 
London, UNITED KINGDOM 
Robert C Schlant, M.D., FACC, Emory Univ. Sch. of 
Med., Atlanta, GA 
10:30 Lovastatin RestenosisTrial-Wiliiam S. Weintraub, M.D., 
FACC, Emory Univ. Hosp., Atlanta, GA 
10:45 Angiopeptin Trials-Jeffrey J. Popma, M.D., FACC, 
Washington Card. Ctr., P.C, Washington, DC 
11 :00 BenestentTrial-Peter P.T. de Jaegers, M.D., Erasmus Univ., 
Rotterdam, THE NETHERLANDS 
1115 Stent Restenosis Study (STRESS) Trial-*Richard A. 
Schatz, M.D., FACe.. Rancho Santa Fe, CA 
11 :30 European Restenosis Trials: Post Angioplasty 
Restenosis Ketanserin (PARK), Coronary Artery 
Restenosis Prevention on Repeated Thromboxane 
Antagonism (CARPORT), Multi-Center European 
Research Trial With Cilazapril After Angioplasty to 
Prevent Transmural Coronary Obstruction and Restenosis 
(MERCATOR)-Patrick W. Serruys, M.D., FACC, Erasmus 
Univ., Rotterdam, THE NETHERLANDS 
~ Prevention of Sudden Cardiac Death 
610 loooj 
Tuesday, March 15, 1994, 10:30 a.m.-Noon 
Georgia World Congress Center, 365W 
Co-Chairmen: John J. Gallagher, M.D., FACC, The Sanger Clin., 
Charlotte, NC 
Eric L. Michelson, M.D., FACC, Hahnemann Univ., 
Philadelphia, PA 
10:30 Identification of Patients at High Risk for SCD-Paul J. 
Troup, M.D., FACC, Cardiovascular Assoc., Inc., Birmingham, 
AL 
10:45 Ongoing Clinical Trials With Antiarrhythmic Drugs and 
Defibrillators-Alfred E. Buxton, M.D., FACC, Temple Univ. 
Sch. of Med., Philadelphia, PA 
11 :00 Results From Heart Failure Trials-Dennis S. Miura, M.D., 
Ph.D., FACC, Albert Einstein Clg. of Med., Bronx, NY 
11 : 15 Approach to the Cardiac Arrest Victim- * Robert J. 
Myerburg, M.D., FACC, Univ. of Miami Med. Ctr., Miami, FL 
11 :30 Third Generation Cardioverter-Defibrillators-*Roger A. 
Winkle, M.D., FACe., Stanford Univ. Sch. of Med., Palo 
Alto, CA 
Be sure to check the Final Program for 
aI/location and program updates. 
xviii PROGRAM 
~ Ethical Issues of Current Concern 
611 
Tuesday, March 15, 1994, 10:30 a.m.-Noon 
Georgia World Congress Center, 254W 
Co-Chairmen: Thomas J. Ryan, M.D., FACC, Boston Univ. Sch. of 
Med., Bostvn, MA 
John F. Williams, Jr., M.D., FACC, Wishard Memorial 
Hosp., Indianapolis, IN 
10:30 "The High Cost of Dying" Revisited-Ann A. Scitovsky, 
M.A., Palo Alto Med. Fdn. & Res. Inst., Palo Alto, CA 
11 :00 Advanced Directives-Do They Work?-Linda Emanuel, 
M.D., Ph.D., Harvard Med. Sch., Boston, MA 
11 :30 Decision Making for Surgical Intervention in the Very 
Elderly-Daniel J. Ullyot, M.D., FACC, Univ. of CA-San 
Francisco, San Francisco, CA 
III How to Satisfy the Editor 
225 
Tuesday, March 15, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 217E 
Co-Chairmen: William W. Parmley, M.D., FACC, Univ. of CA-San 
Francisco, San Francisco, CA 
James T. Willerson, M.D., FACC, Univ. ofTX Med. Sch., 
Houston, TX 
III Optimal Management of Cardiogenic Shock in AMI: Role of Acute Angioplasty 
226 
Tuesday, March 15, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 219E 
-~ 
Co-Chairmen: Eric R. Bates, M.D., FACC, Univ. Hosp., Ann Arbor, MI 
'Richard S. Stack, M.D., FACC, Duke Univ., Durham, 
NC 
III Acute Myocarditis: When Are Cardiac Biopsy and Corticosteroids Indicated? 
227 _ loooj 
Tuesday, March 15, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 216E 
Co-Chairmen: Kenneth Lee Baughman, M.D., FACC, The Johns 
Hopkins Hosp., Baltimore, MD 
Jay W. Mason, M.D., FACC, Univ. of UT Med. Ctr., Salt 
La ke City, UT 
III Anti-Coagulationfor Atrial Fibrillation 
228 _Ioooj 
Tuesday, March 15, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 218E 
Co-Chairmen: 'Michael D. Ezekowitz, M.B., Ch.B., FACC, Yale 
Univ. Sch. of Med., New Haven, CT 
J. Philip Kistler, M.D., MA Gen. Hosp., Boston, MA 
, + See disclosure statement 
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III 
Non-Invasive Assessment of Patients 
Following Myocardial Infarction and 
Thrombolytic Therapy _ 
229 
Tuesday, March 15, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 204E 
Co-Chairmen: William L. Winters, Jr., M.D., FACC, Baylor Clg. of 
Med., Houston, TX 
Barry L. Zaret, M.D., FACC, Yale Univ. Sch. of Med., 
New Haven, CT 
III Pacemaker Therapy in Childhood 
230 _~ 
Tuesday, March 15, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 203E 
Co-Chairmen: John D. Kugler, M.D., FACC, Univ. of NE Med. Ctr., 
Omaha, NE 
Gerald A. Serwer, M.D., FACC, CS. Mott Hosp., Ann 
Arbor,MI 
C Affiliates-in-Training Forum 
409 
Tuesday, March 15, 1994, Noon-2:00 p.m. 
Omni Hotel at CNN Center 
-~ 
Chairman: Joseph S. Alpert, M.D., FACC, Univ. of AZ Hlth. 
Sci. Ctr., Tucson, AZ 
The A ffiliates-in-Training Forum is supported by a grant from 
Bristol-Myers Squibb Co. 
111ft Women in Cardiology: Networking as a 
r--J PositivePoliticalModel _ loooj 
410 
Tuesday, March 15, 1994, Noon-1 :45 p.m. 
Georgia World Congress Center 
Chairman: Marian C Limacher, M.D., FACC, Univ. of FL, 
Gainesville, FL 
Participant: Jacalyn Sherriton, D.Se., Health Management 
Consultants, Hollywood, FL 
f"'l 
311 
Current Treatment Strategies in 
Hypertension 
Tuesday, March 15, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: Marvin Moser, M.D., FACC, Yale Univ. Sch. of Med., 
New Haven, CT 
Participants: 'John Flack, M.D., M.P.H., Univ. of MN, Minneapolis, MN 
Norman Kaplan, M.D., Univ. ofTX Hlth. Sci. Ctr., Dallas, 
TX 
Suzanne Oparil, M.D., FACC, Univ. of AL, Birmingham, 
AL 
Sheldon G. Sheps, M.D., FACC, Mayo Clin., Rochester, 
MN 
JACC February 1994:ii-xxx 
filii Primary PTCA in Acute Myocardial 
rUI Infarction _ 10"01 
312 
Tuesday, March 15, 1994, Noon-1 :45 p.m. 
Georgia World Congress Center 
Chairman: William W. O'Neill, M.D., FACe.. William Beaumont 
Hosp., Royal Oak, MI 
Participants: Ben D. McCallister, M.D., FACC, Mid-America Heart 
Inst., Kansas City, MO 
Nicolaus J. Reifart, M.D., Red Cross Hosp. & Heart Ctr., 
Frankfurt, GERMANY 
Ronald E. Vlietstra, M.B., Ch.B., FACC, Watson Clin., 
Lakeland, FL 
111ft Bi-Directional Glenn-Indications and r--I Complications _ 10"01 
313 
Tuesday, March 15, 1994, Noon-1 :45 p.m. 
Georgia World Congress Center 
Chairman: Hillel Laks, M.D., FACe.. Univ. of CA-Los Angeles 
Med. Ctr., Los Angeles, CA 
Participants: David J. Driscoll, M.D., FACC, Mayo Clin., Rochester, 
MN 
Donald A. Girod, M.D., FACe.. Riley Hosp., Indianapolis, 
IN 
John L. Myers, M.D., Milton S. Hershey Med. Ctr., 
Hershey, PA 
111ft CINE MRI and Ultra Fast Computed r j Tomography-Current Status _ 10"01 
314 
Tuesday, March 15, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: *Bruce H. Brundage, M.D., FAe.C, Harbor-UCLA Med. 
Ctr., Los Angeles, CA 
Participants: Robert Herfkens, M.D., Stanford Univ. Sch. of Med., 
Stanford, CA 
Ronald M. Peshock, M.D, FACe.. Univ. ofTX 
Southwestern, Dallas, TX 
Eulalia Roig, M.D., Hosp. Clin., Barcelona, SPAIN 
John A. Rumberger, M.D., Ph.D., FACC, Mayo Clin., 
Rochester, MN 
111ft When Is Transesophageal Echo Really 
r--I Necessary? _ 10"01 
315 
Tuesday, March 15, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: Anthony N. DeMaria, M.D., FACe.. Univ. of CA-San 
Diego, San Diego, CA 
Participants: *Richard L. Popp, M.D., FACC, Stanford Univ. Med. 
Ctr., Stanford, CA 
Douglas Segar, M.D., FACe.. IN Univ. Sch. of Med., 
Indianapolis, IN 
Shelley Shapiro, M.D, Ph.D., FACe.. Harbor UCLA Med. 
Ctr., Torrance, CA 
* + See disclosure statement 
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111ft How to Get the Most From Anti-Anginal 
l· --I Drugs _ 10"01 
316 
Tuesday, March 15, 1994, Noon-1 :45 p.m. 
Georgia World Congress Center 
Chairman: John O. Parker, M.D., FACC, Kingston Gen. Hosp., 
Kingston, CANADA 
Participants: * Jonathan Abrams, M.D., FACe.. Univ. of NM, 
Albuquerque, NM 
Prakash C Deedwania, M.B.B.S., FACC, VA Med. 
Ctr., Fresno, CA 
*Udho Thadani, M.D., FACC, OK Univ. Hlth. Sci. Ctr., 
Oklahoma City, OK 
111ft How Should Heart Failure Be Treated in r U 11994? _ 10"01 
317 
Tuesday, March 15, 1994, Noon-1 :45 p.m. 
Georgia World Congress Center 
Chairman: Robert J. Cody, M.D., FACC, OH State Univ. Hosp., 
Columbus,OH 
Participants: Eric J. Eichhorn, M.D., FACC, Univ. ofTX S.w. Med. 
Ctr, Dallas, TX 
*Gary S. Francis, M.D., FACC, Univ. of MN, 
Minneapolis, MN 
*Stephen S. Gottlieb, M.D., FACC, Univ. of MD, 
Baltimore, MD 
filii Clinical Decision Making in Valvular Heart 
l- --I Disease: Timing of Surgical Intervention 
318 _~ 
Tuesday, March 15, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: Blase Carabello, M.D., FAe.e.. Med. Univ. of SC, 
Charleston, SC 
Participants: John D. Carroll, M.D., FACe., Univ. of Chicago Med. 
Ctr., Chicago,lL 
Catherine M. Otto, M.D., FACC, Univ. ofWA, Seattle, 
WA 
Mark R. Starling, M.D., FACC, VA Med. Inst., Ann 
Arbor,MI 
filii Invasive Therapyfor Lower Extremity 
rUI Occlusive Disease _ (0"01 
319 
Tuesday, March 15, 1994, Noon-1 :45 p.m. 
Georgia World Congress Center 
Chairman: * Jeffrey M. Isner, M.D., FACC, st. Elizabeth's Hosp., 
Boston, MA 
Participants: RobertA. Graor, M.D., Cleveland Clin. Fdn., Cleveland, 
OH 
*Barrie T. Katzen, M.D., FACC, Miami Vascular Inst., 
Miami, FL 
Peter C Spittel, M.D., Mayo Clin., Rochester, MN 
Visit the ACC'94 Exposition for a 
complete update on cardiovascular 
services and products. 
xx PROGRAM 
111ft New Technologies and Techniques in 1---J Catheter Ablation _ fI!!IIIIIIII 
~ 320 
Tuesday, March 15, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: *G. Neal Kay, M.D., FACC, Univ. of AL, Birmingham, 
AL 
Participants: *Martin Borggrefe, M.D., Med. Klin. & Policlin., 
Munster, GERMANY 
* Anthony C Caruso, M.D., Univ. of AZ, Tucson, AZ 
* Jonathan J. Langberg, M.D., FACC, Emory Univ. 
Hosp., Atlanta, GA 
~ Historical Perspectives in Cardiology 
653 loooj 
Tuesday, March 15, 1994,2:00 p.m.-5:30 p.m. 
Georgia World Congress Center, Auditorium 
Co-Chairmen: Simon Dack, M.D., FACC, New York, NY 
+Borys Surawicl, M.D., FACe., Krannert Inst. of 
Card., Indianapolis, IN 
2:00 The Development of Cardiac Catheterization-*William 
Grossman, M.D., FACC, Harvard Med. Sch., Boston, MA 
2:25 The Calculation of the Area of Stenotic Valves-Richard 
Gorlin, M.D., FACe., Mt. Sinai Med. Ctr., New York, NY 
2:50 The Development of Bedside Hemodynamic Monitor•
ing-*Harold J. C Swan, M.D., Ph.D., FACe., Beverly Hills, 
CA 
3: 1 0 The Evolution of Closed Chest Cardiopulmonary 
Resuscitation-'Myron L. Weisfeldt, M.D., FACe., 
Columbia Presb. Med. Ctr., New York, NY 
3:30 Break 
4:00 
4:20 
Development of an Automatic Implantable 
Defibrillator-John A. Kastor, M.D., FACC, Univ. of MD 
Hosp., Baltimore, MD 
The Beginnings of Coronary Angioplasty-Spencer B. 
King, III, M.D., FACC, Emory Univ. Hosp., Atlanta, GA 
445 The Development of Invasive Electrophysiology-Andrew 
L. Wit, Ph.D., F.A.CC, Columbia Univ., New York, NY 
5: 1 0 Preserving the Past and Perspectives for the Future-W. 
Bruce Fye, Marshfield Clin., Marshfield, WI 
Exhibit product and education searches 
are available for the first time at ACC'94! 
Obtain customized program planners by 
using your Expocard at the centrally 
located computer terminals. 
• + See disclosure statement 
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Controversies in Pediatric 
Cardiology 
Tuesday, March 15, 1994,2:00 p.m.-3:30 p.m. 
Georgia World Congress Center, 362W 
Moderators: Ruth L. Collins-Nakai, M.D., FACC, Univ. of 
Alberta, Edmonton, CANADA 
William W. Pinsky, M.D., FACC, Wayne State 
Univ. Sch. of Med., Detroit, MI 
2:00 Children With Marfan Syndrome Should Be 
Started on a Beta Blocker as Soon as the 
Diagnosis Is Made 
Protagonist: Kenneth G. Zahka, M.D., FACe., Univ. Hosp., 
Cleveland,OH 
Antagonist: Howard P. Gutgesell, M.D., FACC, Univ. of VA 
Med. Sch., Charlottesville, VA 
2:30 Magnetic Resonance Imaging Is More 
Helpful Than Cardiac Ultrasound in Defining 
Cardiac Anatomy for Decision Making in 
Patient Care 
Protagonist: Henry B. Wiles, M.D., FACC, Med. Univ. of SC, 
Charleston, SC 
Antagonist: +Norman H. Silverman, M.D., FACe., Univ. of 
CA, San Francisco, CA 
3:00 Research Should Be Part of a Pediatric 
Cardiology Training Program 
Protagonist: William Friedman, M.D., UCLA Sch. of Med., Los 
Angeles,CA 
Antagonist: J. Hudson Allender, M.D., FACC, Fort Worth, TX 
~ 
612 
Cholesterol: Is It Always True That 
Lower Is Better? 
Tuesday, March 15, 1994,2:00 p.m.-3:30 p.m. 
Georgia World Congress Center, Ballroom 
Co-Chairmen: 'Richard C Pasternak, M.D., FACC, MA Gen. Hosp., 
Boston, MA 
Jacques Rossouw, M.D., Natl. Inst. of Hlth., Bethesda, 
MD 
2 :00 Lowering Cholesterol: Benefits and Risks-Henry 
Blackburn, M.D., Univ. of MN, Minneapolis, MN 
2: 1 5 The Possibilities and Perils of Meta-Analysis: What 
Should We Believe About Cholesterol Lowering?-
• Anthony C Keech, M.D., Oxford Univ., Oxford, UNITED 
KINGDOM 
2:30 Making Cholesterol Policy: Who, How, and What?•
+Steven B. Hulley, M.D., M.P.H., Univ of CA-San Francisco, 
San Francisco, CA 
2:45 Distinguishing Primary From Secondary Prevention•
+Antonio M. Gotto, Jr., M.D., FACe., Methodist Hosp., 
Houston, TX 
3:00 Lowering Cholesterol: The Dietary Hypothesis-Ray H. 
Rosenman, M.D., FACC, Mt. Zion Med. Ctr.-Univ. of CA, 
San Francisco, CA 
3: 15 The Cholesterol Crusade: Has It Been Oversold?•
Jacques Rossouw, M.D., Nat. Inst. of Hlth., Bethesda, MD 
lACC February 1994:ii-xxx 
rmn Newer Surgical Options for the Support .1 of the Failing Heart locol 
613 
Tuesday, March 15, 1994,2:00 p.m.-3:30 p.m. 
Georgia World Congress Center, 254W 
Co-Chairmen: Daniel J. Ullyot, M.D., FACe., Univ. of CA, San 
Francisco, CA 
Gus J. Via hakes, M.D., FACC, MA Gen. Hosp., Boston, 
MA 
2 :00 Post-Cardiotomy Support With Temporary Ventricular 
Assist-RobertA. Guyton, M.D., FACC, Emory Univ., 
Atlanta, GA 
2:20 Extended Cardiac Support With Implanted Ventricular 
Assist Systems-O. Howard Frazier, M.D., FACC, TX Heart 
Inst., Houston, TX 
2:40 Cardiomyoplasty: CurrentStatus-LarryW. Stephenson, 
M.D., FACC, Wayne State Univ. Hosp., Detroit, MI 
3 :00 Long-Term Experience With Cardiomyoplasty- * Ray Chu•
Jeng Chiu, M.D., Ph.D., Montreal Gen. Hosp., Montreal, 
CANADA 
~ Joint Symposium: InterAmerican Society of Cardiology/American College of Cardiology locol 
614 
Tuesday, March 15, 1994, 2:00 p.m.-3:30 p.m. 
Georgia World Congress Center, 264W 
Rheumatic Heart Disease: What's New? 
Co-Chairmen: Sylvan Lee Weinberg, M.D., FACe., Dayton, 
OH 
Mario F.C Maranhao, M.D., FACe., Univ. of 
Parana Med. Sch, Curitiba, BRAZIL 
2:00 The Non-Invasive Diagnosis of Valvular Heart 
Disease-Miguel A. Quinones, M.D., FACe., 
Methodist Hosp., Houston, TX 
2:30 Valve Prosthesis, Anti-Coagulants, and Preg•
nancy-Eduardo Salazar, M.D., FACe., Inst. de 
Nacional de Cardiol., Mexico City, MEXICO 
3:00 Surgical Valvuloplasty vs. Replacement by 
Prosthesis-Domingo M. Braile, M.D., Braile Biomedica, 
Sao Jose do Rio Preto, BRAZIL 
111 How to Manage End Stage Heart Failure 
231 _ locol 
Tuesday, March 15, 1994, 2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 219E 
Co-Chairmen: *Maria Rosa Costanzo, M.D., FACe., Loyola Univ. 
Med. Ctr., Maywood, IL 
Uri Elkayam, M.D., FACC, Univ. of S. CA Sch. of Med., 
Los Angeles, CA 
* + See disclosure statement 
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JW1 Cardiopulmonary Resuscitation: New 
••• Techniques, Results, and Ethical Dilemmas 
232 _ locol 
Tuesday, March 15, 1994, 2:30 p.m.-3:30 p.m. 
Georgia World Congress Center 216E 
Co-Chairmen: Gordon A. Ewy, M.D., FACe., Univ. Heart Ctr., 
Tucson, AZ 
Jeffrey B. Sack, M.D., Univ. of CA Med. Ctr., Los Angeles, 
CA 
III Stentsfor"BaiIOut" 
233 
Tuesday, March 15, 1994,2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 218E 
Co-Chairmen: *Richard A. Schatz, M.D., FACC, Rancho Santa Fe, 
CA 
234 
*Ulrich Sigwart, M.D., FACe., Royal Brompton Ntl. 
Heart Hosp., London, UNITED KINGDOM 
Howto Perform and Interpret Stress 
Echocardiography _ locol 
Tuesday, March 15, 1994, 2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 217E 
Co-Chairmen:*William F. Armstrong, M.D., FACC, Univ. of MI 
Hosp., Ann Arbor, MI 
Linda J. Crouse, M.D., FACe., Mid-America Heart Inst., 
Kansas City, MO 
JW1 Evaluation and Management of Adults 
••• With Congenital Heart Disease _ locol 
235 
Tuesday, March 15, 1994, 2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 203E 
Co-Chairmen: Arthur Garson, Jr., M.D., M.P.H., FACC, Duke Univ. 
Med. Ctr., Durham, NC 
Joseph K. Perloff, M.D., FACC, Univ. of CA, Los 
Angeles, CA 
111 Pathogenesis of Atherosclerosis 
236 _Iocol 
Tuesday, March 15, 1994, 2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 204E 
Co-Chairmen: M. Rene Malinow, M.D., OR Primate Res. Ctr., 
Beaverton, OR 
William O. Roberts, M.D., FACC, Dallas, TX 
xxii PROGRAM 
rmn Transesophageal Echocardiography: .1 Current and Future Applications 
615 10001 
Tuesday, March 15, 1994, 4:00 p.m.-5:30 p.m. 
Georgia World Congress Center, Ballroom 
Co-Chairmen: +Raimund Erbel, M.D., F.A.CC, Johannes Gutenberg 
Univ., Mainz, GERMANY 
Ryozo Omoto, M.D., Saitama Med. Sch., Saitama, 
JAPAN 
4:00 Prosthetic Valves-Harry Rakowski, M.D., Toronto Hosp., 
Toronto, CANADA 
4:15 AorticDissection-Martin E. Goldman, M.D., F.A.CC, Mt. 
Sinai Med. Ctr., New York, NY 
4:30 The Critically III Patient-M ichael H. Picard, M.D., F.A.CC, 
MA Gen. Hosp., Boston, MA 
4:45 CryptogenicStroke-* Arthur J. Labovitz, M.D., F.A.CC, St. 
Louis Univ., St. Louis, MO 
5:00 New Methods of Image Orientation-Natesa G. Pandian, 
M.D., F.A.CC, New England Med. Ctr., Boston, MA 
III Howto Manage End Stage Heart Failure 
237 _ 10001 
Tuesday, March 15, 1994,4:00 p.m.-5:00 p.m. 
Georgia World Congress Center, 218E 
Co-Chairmen: Arthur M. Feldman, M.D., Ph.D., F.A.CC, John 
Hopkins Sch. of Med., Baltimore, MD 
Lynne Warner Stevenson, M.D., F.A.CC, Univ. of CA 
Sch. of Med., Los Angeles, CA 
III 
When Should Thrombolytic Therapy Be 
Usedforthe Management of Pulmonary 
Embolism? _ 10001 
238 
Tuesday, March 15, 1994, 4:00 p.m.-5:00 p.m. 
Georgia World Congress Center, 216E 
Co-Chairmen: 'Samuel Z. Goldhaber, M.D., FACC, Brigham & 
Women's Hosp., Boston, MA 
'Arthur A. Sasahara, M.D., F.A.CC, Abbott Laboratories, 
Abbott Park, IL 
JW1 Role of Mechanical Methods of 
••• ReperfusionDuringMI _ 10001 
239 
Tuesday, March 15, 1994, 4:00 p.m.-5:00 p.m. 
Georgia World Congress Center, 203E 
Co-Chairmen: 'Raymond J. Gibbons, M.D., F.A.CC, Mayo Clin., 
Rochester, MN 
Robert H. Jones, M.D., F.A.CC, Duke Univ. Med. Ctr., 
Durham, NC 
Visit the A CC'94 Exposition for a 
complete update on cardiovascular 
services and products. 
, + See disclosure statement 
JACC February 1994:ii-xxx 
III Surgical Treatment of Congenital Aortic Valve Disease _ ~ ~ 240 
Tuesday, March 15, 1994,4:00 p.m.-5:00 p.m. 
Georgia World Congress Center, 217E 
Co-Chairmen: Albert D. Pacifico, M.D., F.A.CC, Univ. of AL, 
Birmingham, AL 
Robert K. Salley, M.D., Univ. of KY, Lexington, KY 
III Management of Atrial Fibrillation 
241 _ 10001 
Tuesday, March 15, 1994,4:00 p.m.-5:00 p.m. 
Georgia World Congress Center, 204E 
Co-Chairmen: Melvin D. Cheitlin, M.D., F.A.CC, Univ. of CA, San 
Francisco, CA 
Adolph M. Hutter, Jr., M.D., F.A.CC, MA Gen. Hosp., 
Boston, MA 
III Pediatric Echocardiography 
242 
Tuesday, March 15, 1994,4:00 p.m.-5:00 p.m. 
Georgia World Congress Center, 219E 
Co-Chairmen: Randolph P. Martin, M.D., F.A.CC, Emory Univ. Sch. of 
Med., Atlanta, GA 
*Samuel B. Ritter, M.D., F.A.CC, Cornell Univ., New 
York, NY 
1:1 Medical and Surgical Management of 
Iml Chronic Mitral and Aortic Regurgitation 
511 !OOOI 
Tuesday, March 15, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 264W 
Chairman: Blase Carabello, M.D., F.A.CC, Med. Univ. of SC, 
Charleston,SC 
Participants: Siavosh Bozorgi, M.D., F.A.CC, Dayton, OH 
Alain Carpentier, M.D., Ph.D., FACC, Univ. of Paris, 
Paris, FRANCE 
Michael H. Crawford, M.D., FACC, The Univ. of NM, 
Albuquerque, NM 
1:1 New Directions in Myocardial Perfusion 
Imllmaging 10001 
512 
Tuesday, March 15, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 254W 
Chairman: James T. Willerson, M.D., F.A.CC, Univ. of TX Med. 
Sch., Houston, TX 
Participants: Daniel S. Berman, M.D., F.A.CC, Cedars-Sinai Med. 
Ctr., Los Angeles, CA 
Lynne L. Johnson, M.D., F.A.CC, Univ. of AL, 
Birmingham, AL 
*Frans J. Th. Wackers, M.D., Ph.D., F.A.CC, Yale Univ. 
Sch. of Med., New Haven, CT 
JACC February 1994:ii-xxx 
B Endothelin,1994 
513 
Tuesday, March 15, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 364W 
Chairman: * James H. Chesebro, M.D., FACe., MA Gen. Hosp., 
Boston, MA 
Participants: Kenneth D. Bloch, M.D., MA Gen. Hosp., Boston, MA 
John Burnett, M.D., Mayo Clin., Rochester, MN 
*Gabor M. Rubanyi, M.D., Ph.D., Berlex Biosciences, 
Richmond, CA 
B Prevention of Sudden Cardiac Death 
514 
Tuesday, March 15, 1994,7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 265W 
Chairman: * John Philip Di Marco, M.D., Ph.D., FACe., Univ. of 
VA Med. Ctr., Charlottesville, VA 
Participants: H. Leon Greene, M.D., FAe.e., Univ. ofWA, Seattle, 
WA 
B 
515 
Craig M. Pratt, M.D., FAe.C, Baylor Clg. of Med., 
Houston, TX 
*D. George Wyse, M.D., Ph.D., FAe.e., The Univ. of 
Calgary, Calgary, CANADA 
New Therapeutic Approaches to 
Restenosis After Coronary Angioplasty 
tom 
Tuesday, March 15, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 365W 
Chairman: *John S. Douglas, Jr., M.D., FACe., Emory Univ. 
Hosp., Atlanta, GA 
Participants: Ian.!. Sarembock, M.B., Ch.B., FACC, Univ. of VA Sch. 
of Med., Charlottesville, VA 
*George W. Vetrovec, M.D., FAe.e., Med. Clg. of VA, 
Richmond, VA 
*Patrick L. Whitlow, M.D., FAe.e., Cleveland Clin. Fdn., 
Cleveland,OH 
B Current Management of Atrial Fibrillation 
516 lODol 
Tuesday, March 15, 1994,7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 362W 
Chairman: *Rodney H. Falk, M.D., FAe.e., Boston Univ. Sch. of 
Med., Boston, MA 
Participants: *Elliott M. Antman, M.D., FAe.e., Brigham & Women's 
Hosp., Boston, MA 
*Kenneth A. Ellenbogen, M.D., FACe., Med. Clg. of 
VA, Richmond, VA 
Philip J. Podrid, M.D., FAe.e., Univ. Hosp., Boston, MA 
PROGRAM 
1:1 Direct Angioplasty vs. Thrombolytic 
Iml Therapy in Acute Myocardial I nfarction 
xxiii 
517 lODol 
Tuesday, March 15, 1994,7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 261 W 
Chairman: Donald A. Rothbaum, M.D., FAe.e., Northside Card., 
Indianapolis, IN 
Participants: *Robert M. Califf, M.D., FAe.e., Duke Univ. Med. Ctr., 
Durham, NC 
B 
518 
*Raymond J. Gibbons, M.D., FAe.e., Mayo Clin., 
Rochester, MN 
*Gregg W. Stone, M.D., F.A.Ce., The Cardiovascular 
Inst., Mountain View, CA 
How Should Heart Failure Be Treated in 
19947 JODol 
Tuesday, March 15, 1994, 7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 257W 
Chairman: Jay N. Cohn, M.D., FAe.e., Univ. of MN Med. Sch., 
Minneapolis, MN 
Participants: Robert DiBianco, M.D., FAe.e., Washington, DC 
* Arthur M. Feldman, M.D., Ph.D., FAe.e., Johns 
Hopkins Sch. of Med., Baltimore, MD 
B 
519 
Andrew L. Smith, M.D., FAe.e., The Emory Clin., 
Atlanta, GA 
Pediatric Cardiac Transplantation: An 
Expanding Horizon 
Tuesday, March 15, 1994,7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 363W 
Chairman: Linda J. Addonizio, M.D., FAe.e., Columbia•
Presbyterian Med. Ctr, New York, NY 
Participants: David Baum, M.D., FACC, Stanford Univ. Med. Ctr., 
Stanford, CA 
David J. Driscoll, M.D., FACe., Mayo Clin., Rochester, 
MN 
Jay Fricker, M.D., Children's Hosp., Pittsburgh, PA 
1:11 New and Evolving Echocardiography 
Iml Techniques/Advances in Echo 
520 (0001 
Tuesday, March 15, 1994,7:30 p.m.-9:00 p.m. 
Georgia World Congress Center, 361W 
Chairman: Sanjiv Kaul, M.B.B.S., FAe.C, Univ. of VA, 
Charlottesville, VA 
Participants: *Richard E. Kerber, M.D., FAe.e., Univ. of IA Hosp., 
Iowa City, IA . 
Joseph A. Kisslo, Jr., M.D., FACe., Duke Univ. Med. 
Ctr., Durham, NC 
Stephen Sanders, M.D., Children's Hosp. Med. Ctr., 
Boston, MA 
Be sure to check the Final Program for all 
location and program updates. 
* + See disclosure statement 
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Jogging/Walking Event 
6:30a.m. Rain or shine. Enjoy a cool-down continental 
breakfast at the conclusion of the event. 
The jogging/walking event is sponsored by a 
grant from Lederle Laboratories and Advantus 
Pharmaceuticals. 
Registration 
Wednesday, March 16, 1994,8:00 a.m.-5:00 p.m. 
Georgia World Congress Center, Hall E 
Exposition 
Wednesday, March 16, 1994,9:00 a.m.-5:00 p.m. 
Georgia World Congress Center, Halls D-H 
The Exposition offers you the opportunity to obtain first-hand the 
latest information on pharmaceutical products, equipment, 
medical devices, and other services. With nearly 400 companies, 
you maximize your time, and still have the opportunity for one•
on-one exchange with knowledgeable industry representa•
tives. Exhibit product searches are available for the first time at 
ACC'94. Obtain a customized search by using your Expocard 
at the centrally located computer terminals. Users select the 
category(ies) of interest, then read or print a list of exhibitors 
offering the product/service. 
f"'n Mechanisms Contributing to the 
.1 Development of Heart Failure ~ 
654 
Wednesday, March 16, 1994,8:30 a.m.-Noon 
Georgia World Congress Center, Auditorium 
Co-Chairmen : *Gary S. Francis, M.D., FACC, Univ. of MN, 
Minneapolis, MN 
Barry M. Massie, M.D., FACC, Univ. of CA-San 
Francisco, San Francisco, CA 
8: 30 Mechanisms Underlying the Depression of Cardiac 
Contractility-James P. Morgan, M.D., Ph .D., FACC, Beth 
Israel Hosp., Boston, MA 
9 :00 Defects in the Peripheral Vasculature-S tua rt Katz, M. D., 
Columbia Univ., New York, NY 
9: 30 Activation of Neurohormonal Mechanisms-David W. 
Ferguson, M .D., FACC, Bethesda, MD 
10:00 Break 
10:30 Physiologic Role of the Kidney in Heart Failure-John 
Burnett, M.D., Mayo Clin., Rochester, MN 
11 :00 Mechanisms Contributing to Exercise Intolerance-Donna 
Mancini, M .D., Columbia Univ., New York, NY 
11 :30 ElectrophysiologicAbnormalities of Heart Failure-William 
G. Stevenson, M.D., FACC, Univ. of CA-Los Angeles, Los 
Angeles, CA 
* + See disclosure statement 
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C Controversies in Cardiology 
412 
Wednesday, March 16, 1994,8:30 a.m.-Noon 
Georgia World Congress Center, Ballroom 
Moderators: Richard O. Russell, Jr., M.D., FACC, 
Cardiovascular Assoc., Inc., Birmingham, AL 
R. Joe Noble, M.D., FACC, Northside Card., 
IndianapOlis, IN 
8:30 PTCA Is Preferred Over Thrombolytic Therapy 
for Acute Myocardial Infarction 
Protagonist: GeoffreyO. Hartzler, M.D., FACC, Mid-America 
Heart Inst., Kansas City, MO 
Antagonist: *Peter Sleight, M.D., FACC, John Radcliffe 
Hosp., Oxford, UNITED KINGDOM 
9: 15 Cardiologists Should Routinely Administer 
Estrogen Replacement Therapy in 
Postmenopausal Women 
Protagonist: Charles Hennekens, M.D., Brigham & Women's 
Hosp ., Boston, MA 
Antagonist: Richard P. Lewis, M .D., FACC, OH State Univ., 
Columbus,OH . 
10:00 Intermission 
10:30 The Routine Use of Class I-A Anti-Arrhythmic 
Agents to Prevent Re-Current Atrial 
Fibrillation Should Be Abandoned 
Protagonist: Vance John Plumb, M .D., FACC, Univ. of AL -
Birmingham, Birmingham, AL 
Antagonist: Jeremy N. Ruskin, M.D., FACC, MA Gen. Hosp., 
Boston, MA 
11 : 1 5 Implantable Cardioverter-Defibrillators Are 
Better Than Drug Therapy in Patients With 
Life Threatening Ventricular Arrhythmias 
Protagonist: Leonard S. Dreifus, M.D., FACC, Hahnemann 
Univ., Philadelphia, PA 
Antagonist: Soo Gyum Kim, M.D., FACC, Bronx, NY 
CMf Credits 
Look for the eME Credit Statement 
for Registration Records in the 
Final Program. 
lACC February 1994:ii-xxx 
rmn Hypertrophic Cardiomyopathy: New .1 Advances 10Doj 
616 
Wednesday, March 16, 1994, 8:30 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 365W 
Co-Chairmen: John F. Goodwin, M.D., FACC, London, UNITED 
KINGDOM 
E. Douglas Wigle, M.D., FACC, Toronto Gen. Hosp., 
Toronto, CANADA 
8:30 GenetiC Basis-Christine Seidman, M.D., Harvard Med. Sch., 
Boston, MA 
8:45 Dangerous Disorder in Childhood?-Barry Joel Maron, M.D., 
FACC, Minneapolis Heart Inst. Fdn., Minneapolis, MN 
9:00 A Benign Disorderin OlderPatients?-Leonard M. Shapiro, 
M.D., FACC, Papworth Hosp., Cambridge, UNITED 
KINGDOM 
9: 15 Management of Arrhythmias-William J. McKenna, M.D., 
FACC, St. George's Hosp. Med. Sch., London, UNITED 
KINGDOM 
9:30 The Role of Pacing-Martin A. Alpert, M.D., FACC, Univ. of 
S. AL, Mobile, AL 
rmn New Concepts in the Non-Invasive .1 Assessment of Valvular Heart Disease 
617 JODOj 
Wednesday, March 16, 1994,8:30 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 265W 
Co-Chairmen: Navin C Nanda, M.D., FACC, Univ. of AL•
Birmingham, Burmingham, AL 
Ajit Yoganathan, Ph.D., GA Inst. of Tech., Atlanta, GA 
8:30 Doppler Gradients and Valve Areas: Do They Have the 
Same Meaning for Prosthetic Valves?-Gerald Maurer, 
M.D., FACC, Univ. of Vienna, Vienna, AUSTRIA 
8:45 
9:00 
Limitation of Jet Area for Quantifying Regurgitation•
+Ajit Yoganathan, Ph.D., GA Inst. of Tech., Atlanta, GA 
Conservation of Momentum in Regurgitation Jets•
James D. Thomas, M.D., FACC, Cleveland Clin. Fdn., 
Cleveland, OH 
9: 15 Conservation of Mass: Theory and Applications of 
Proximal 150-Velocity Surface Area (PISA )-Robert A. 
Levine, M.D., FACC, MA Gen. Hosp., Boston, MA 
9: 30 Effective and Visualized Regurgitant Orifice Area-* A. 
Jamil Tajik, M.D., FACe., Mayo Clin., Rochester, MN 
9:45 Evaluation of Deep Tissue Periprosthetic Infections and 
Fistulas-William J. Stewart, M.D., FACC, Cleveland Clin. 
Fdn., Cleveland, OH 
r.1 Management of Cardiac Transplant in 
••• Pediatric Patients _ 10Doj 
243 
Wednesday, March 16, 1994, 9:00 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 203E 
Co-Chairmen: Linda J. Addonizio, M.D., FACC, Columbia Presb. 
Med. Ctr., New York, NY 
Mark M. Boucek, M.D., FACC, Univ. of CO, Denver, CO 
* + See disclosure statement 
III FDA Approval Process 
244 
PROGRAM 
Wednesday, March 16, 1994, 9:00 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 217E 
Co-Chairmen: Raymond J. Lipicky, M.D., Food and Drug Admin., 
Rockville, MD 
Wolf Sapirstein, M.B., Ch.B., M.P.H., Food and Drug 
Admin., Rockville, MD 
When IsAmiodaroneJustified inthe 
xxv 
III 
Treatment of Cardiac Arrhythmias: What 
Dose to Use and How Should the Patient 
Be Monitored? _ JODOj 
245 
Wednesday, March 16, 1994,9:00 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 218E 
Co-Chairmen: * John A. Cairns, M.D., FACC, McMaster Univ., 
Hamilton, CANADA 
Robert Slama, M.D., FACC, Hosp. Lariboisiere, Paris, 
FRANCE 
r.1 The Utility of Magnetic Resonance Imaging 
••• in Cardiac Diagnosis _ JODOj 
246 
Wednesday, March 16, 1994,9:00 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 216E 
Co-Chairmen: *Gerald M. Pohost, M.D., FACC, Univ. of AL, 
Birmingham, AL 
247 
Warren J. Manning, M.D., FACC, Beth Israel Hosp., 
Boston, MA 
Pericardial Heart Disease 
Wednesday, March 16, 1994, 9:00 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 219E 
Co-Chairmen: Martin M. LeWinter, M.D., FACC, Univ. of VT, 
Burlington, VT 
248 
Ralph Shabetai, M.D., FACC, VA Med. Ctr., San 
Diego, CA 
Silent Myocardial Ischemia-Does It 
Require Treatment, and If So, With What? _m 
Wednesday, March 16, 1994,9:00 a.m.-1 0:00 a.m. 
Georgia World Congress Center, 204E 
Co-Chairmen: Prakash C Deedwania, M.B.B.S., FACC, VA Med. 
Ctr., Fresno, CA 
Andrew P. Selwyn, M.D., FACC, Brigham & Women's 
Hosp., Boston, MA 
xxvi 
~ 
618 
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Diastolic Dysfunction: Pathophysiology and 
Pharmacologic Modrtication 
Wednesday, March 16, 1994, 10:30 a.m.-Noon 
Georgia World Congress Center, 365W 
Co-Chairmen: Robert O. Bonow, M.D., FACe., Northwestern Univ. 
Med. Sch., Chicago, IL 
*William Grossman, M.D., FACe., Harvard Med. Sch., 
Boston, MA 
10:30 The Physiology of Cardiac Diastole-James P. Morgan, 
M.D., Ph.D., FACC, Beth Israel Hosp., Boston, MA 
10:45 Clinical Disorders Associated With Diastolic Dysfunction•
Robert o. Bonow, M.D., FACe., Northwestern Univ. Med. 
Sch., Chicago, IL 
11 :00 Echocardiographic Measures of Diastolic Function•
Arthur E. Weyman, M.D., FACe., MA Gen. Hosp., Boston, 
MA 
11 : 1 5 Radionuclide Techniques for Measurement of Diastolic 
Function-Steven C Port, M.D., FACe., Sinai Samaritan 
Med. Ctr., Milwaukee, WI 
11 :30 Pharmacologic Modification of Diastolic Function•
*Randall M. Zusman, M.D., FACe., MA Gen. Hosp., Boston, 
MA 
Two-and Three-Dimensional rmn Echocardiography: Advances and Future .1 Directions locoj 
619 
Wednesday, March 16, 1994, 10:30 a.m.-Noon 
Georgia World Congress Center, 265W 
Co-Chairmen: *Harvey Feigenbaum, M.D., FACe., Univ. Hosp., 
Indianapolis, IN 
Randolph P. Martin, M.D., FACe., Emory Univ. Sch. of 
Med., Atlanta, GA 
10:30 Intravascular Ultrasound-* Peter J. Fitzgerald, M.D., Ph.D., 
Univ. of CA-San Francisco, San Francisco, CA 
10:45 Stress Echocardiography-* Harvey Feigenbaum, M.D., 
FACe., Univ. Hosp., Indianapolis, IN 
11 :00 Multiplane Transesophageal Echocardiography-Peter 
Hanrath, M.D., FACe., Med. Clin.l, Aachen, GERMANY 
11: 15 Three-Dimensional Echocardiography-Michael H. Picard, 
M.D., FACC, MA Gen. Hosp., Boston, MA 
11:30 
11:45 
AutomaticBorderDetection-*Edward A. Geiser, M.D., 
FACC, Univ. of FL Clg. of Med., Gainesville, FL 
TissueCharacterization-*Julio E. Perez, M.D., FACC, 
Washington Univ., st. Louis, MO 
III Management and Prognosis of Hypertrophic Cardiomyopathies 
249 .locoj 
Wednesday, March 16, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 219E 
Co-Chairmen: Barry Joel Maron, M.D., FACe., Minneapolis Heart Inst. 
Fdn., Minneapolis, MN 
E. Douglas Wigle, M.D., FACe., Toronto Gen. Hosp., 
Toronto, CANADA 
* + See disclosure statement 
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III Intravascular Ultrasound Imaging 
250 • locoj 
Wednesday, March 16, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 216E 
Co-Chairmen: Martin B. Leon, M.D., FACC, Washington Hosp. Or., 
Washington, DC 
Steven E. Nissen, M.D., FACe., Cleveland Clin. Fdn., 
Cleveland,OH 
III Approach to the Patient With Ventricular Arrhythmias and a Prolonged QTc 
251 .locoj 
Wednesday, March 16, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 204E 
Co-Chairmen: Leonard S. Gettes, M.D., FACe., Univ. of NC, Chapel 
Hill,NC 
D. George Wyse, M.D., Ph.D., FACe., The Univ. of 
Calgary, Calgary, CANADA 
III Surgery of the Aorta 
252 
Wednesday, March 16, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 203E 
Co-Chairmen: Robert J. Adolph, M.D., FACe., Univ. of Cincinnati, 
Cincinnati,OH 
Nicholas Thomas Kouchoukos, M. D .. FA C e., 
Washington Univ. Sch. of Med., St. Louis, MO 
III Update on the Management of Hypertension in Afro-Americans 
253 
Wednesday, March 16, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 218E 
Co-Chairmen: Dallas Hall, M.D., Emory Univ., Atlanta, GA 
• 
III Management of Abrupt Closure and/ or Severe Dissection After PTCA 
254 
Wednesday, March 16, 1994, 10:30 a.m.-11 :30 a.m. 
Georgia World Congress Center, 217E 
Co-Chairmen: Spencer B. King, III, M.D., FACe., Emory Univ. Hosp., 
Atlanta, GA 
Mohsen Sakhaii, M.D., FACC, Dayton, OH 
locoj 
Audio Tapes 
You will find a form to purchase audio tapes 
of selected ACC'94 sessions (including Meet 
the Experts) in the Final Program. 
JACC February 1994:ii-xxx 
f"') Coronary Artery Disease in Women 
321 _ 10001 
Wednesday, March 16, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: Pamela S. Douglas, M.D., FACC, Beth Israel Hosp., 
Boston, MA 
Participants: Cindy L. Grines, M.D., FACC, William Beaumont Hosp., 
Royal Oak, MI 
Charles Hennekens, M.D., Brigham & Women's Hosp., 
Boston, MA 
NicholasThomas Kouchoukos, M.D., FACC, Jewish 
Hosp.-Wash. Univ. Med. Ctr., St. Louis, MO 
111ft Diagnostic Methods in Peripheral Arterial· 
l---j Disease _ ~ 
322 ~ 
Wednesday, March 16, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: * John A. Spittell, Jr., M.D., FACC, Mayo Clin., 
Rochester, MN 
Participants: Gerald Dorros, M.D., FACC, Milwaukee Heart & Vase. 
Clin., Milwaukee, WI 
* Julio C Palmaz, M.D., Univ. of TX Hlth. Sci. Ctr., San 
Antonio, TX 
Christopher J. White, M.D., FACC, Oschner Clin., New 
Orleans, LA 
f"') Emergent Treatment of Arrhythmias 
323 _ 10001 
Wednesday, March 16, 1994, Noon-1 :45 p.m. 
Georgia World Congress Center 
Chairman: Jeffrey L. Anderson, M.D., FACC, L.D.S. Hosp., Salt 
Lake City, UT 
Participants: Mark E. Josephson, M.D., FACC, Beth Israel Hosp., 
Boston, MA 
*Gerald V. Naccarelli, M.D., FACC, Univ. ofTX Med. 
Sch., Houston, TX 
Bramah N. Singh, M.D., PhD, FACC, Wadsworth VA 
Hosp., Los Angeles, CA 
f"'J Three-Dimensional Echocardiography 
324 _ 10001 
Wednesday, March 16, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: James B. Seward, M.D., FACC, Mayo Clin., 
Rochester, MN 
Participants: *Donald King, M.D., Columbia Univ., New York, NY 
Natesa G. Pandian, M.D., FACC, Tufts-New England 
Med. Ctr., Boston, MA 
James L. Weiss, M.D., FACC, The Johns Hopkins Hosp., 
Baltimore, MD 
111ft Treatment Options for End-Stage Heart 
l" j Failure _ ~ 
I~ 325 
Wednesday, March 16, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
* + See disclosure statement 
PROGRAM 
Chairman: Kanu Chatterjee, M.D., FACC, Univ. of CA-San 
Francisco, San Francisco, CA 
xxvii 
Participants: Donald F. Hammer, M.D., FACC, Wright State Univ., 
Dayton,OH 
Roger M. Mills, Jr., M.D., FACe, Univ. of FL, 
Gainesville, FL 
Hannah A. Valantine, M.D., FACC, Stanford Univ., 
Stanford, CA 
111ft Kawasaki Disease-Long-term Follow-Up l---j and Complications of Coronary Aneurysms 
326 _10001 
Wednesday, March 16, 1994, Noon-1 :45 p.m. 
Georgia World Congress Center 
Chairman: Welton M. Gersony, M.D., FACC, Babies Hosp., New 
York, NY 
Participants: Jane Newburger, M.D., Children's Hosp., Boston, MA 
David C Schwartz, M.D., FACC, Children's Hosp., 
Cincinnati,OH 
Masato Takahashi, M.D., FACC, Children's Hosp. of 
LA, Los Angeles, CA 
f"') Congenital Heart Disease in Adults 
327 _m 
Wednesday, March 16, 1994, Noon-1 :45 p.m. 
Georgia World Congress Center 
Chairman: Kathryn H. Ehlers, M.D., FACC, NY Hosp.-Cornell 
Med. Ctr., New York, NY 
Participants: Joseph K. Perloff, M.D., FACC, Univ. of CA-Los 
Angeles, Los Angeles, CA 
Kevin Turley, M.D., FACC, CA Pacific Med. Ctr., San 
Francisco, CA 
L. George Veasy, M.D., Univ. of UT Sch. of Med., Salt 
Lake City, UT 
f"') Intracoronary Ultrasound: Lessons Learned 
328 _10001 
Wednesday, March 16, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: *Paul G. Yock, M.D., FACC, Univ. of CA, San 
Francisco, CA 
Participants: *Charles McKay, M.D., Univ. of lA, Iowa City, IA 
Robert J. Siegel, M.D., FACC, Cedars-Sinai Med. Ctr., 
Los Angeles, CA 
Jonathan M. Tobis, M.D., FACC, Univ. of CA, Irvine, CA 
111ft Lesion Specific Application of New 
rUj InterventionalDevices _ joool 
329 
Wednesday, March 16, 1994, Noon-1 :45 p.m. 
Georgia World Congress Center 
Chairman: Simon H. Stertzer, M.D., FACC, San Francisco Heart 
Inst., San Francisco, CA 
Participants: Richard R. Heuser, M.D., FACC, AZ Heart Inst. Fdn., 
Phoenix,AZ 
*Thomas J. Linnemeier, M.D., FACC, St. Vincent's 
Hosp., Indianapolis, IN 
Richard K. Myler, M.D., FACC, San Francisco Heart 
Inst., San Francisco, CA 
xxviii PROGRAM 
JIIII Timing of Surgical Intervention for Mitral 
r--j Insufficiency _ 10001 
330 
Wednesday, March 16, 1994, Noon-1:45 p.m. 
Georgia World Congress Center 
Chairman: Lawrence H. Cohn, M.D., FACe., Brigham & 
Women's Hosp., Boston, MA 
Participants: Blase Carabello, M.D., FACe., Med. Univ. of SC, 
Charleston, SC 
C 
413 
Robert A. O'Rourke, M.D., FACe., Univ. ofTX Hlth. Sci. 
Ctr., San Antonio, TX 
J. Scott Rankin, M.D., F .A.CC, Vanderbilt Univ., 
Nashville, TN 
Business Meeting of the College 
Wednesday, March 16, 1994, 1:45 p.m.-2:00 pm. 
Georgia World Congress Center, 362W 
The Annual Business Meeting for the transaction of necessary 
College business will begin promptly at 1 :45 p.m. Hear the 
reports of the President and Secretary of the College, and take 
part in the election of officers and trustees. 
Introductory Remarks by the College President 
List of Deceased Members During the Past Year 
Report of the Secreta ry 
Report of the Treasurer 
Report of the Nominating Committee 
New Business 
Motion to Adjourn 
rmn Therapeutic Choices in Cardiovascular 
.1 Pharmacology 10001 
655 
Wednesday, March 16, 1994, 2:00 p.m.-5:00 p.m. 
Georgia World Congress Center, Ballroom II 
Co-Chairmen: Rolf M. Gunnar, M.D., FACC, Gunnar Med. Grp., 
Riverside, IL 
S. H. Rahimtoola, M.D., FACC, USC Sch. of Med., 
Los Angeles, CA 
2:00 For the Patient at Risk of Thromboembolism, Should 
We Be Using Antiplatelet Drugs or Anticoagulants?•
*Michael D. Ezekowitz, M.B., Ch.B., FACC, Yale Univ. Sch. 
of Med., New Haven, CT 
2:30 For the Patient With Coronary Artery Disease, Should 
We Be Using Beta-Blockers or Calcium Channel 
Blockers?-*Carl J. Pepine, M.D., FACC, Univ. of FL, 
Gainesville, FL 
3:00 For the Patient With Ventricular Arrhythmias, Should We 
Be Using a Beta-Blocker or a Class I Antiarrhythmic 
Drug?-Jay W. Mason, M.D., FACe., Univ. of UT Med. Ctr., 
Salt Lake City, UT 
3:30 Break 
4:00 For the Patient With Rapid Atrial Fibrillation, Should We 
Be Using Digitalis, a Beta-Blocker, or a Calcium Channel 
Blocker?-*Rodney H. Falk, M.D., FACC, Boston Univ. Sch. 
of Med., Boston, MA 
4:30 For the Patient With Chronic Heart Failure, Should We Be 
Using a Vasodilator or a Converting-Enzyme Inhibitor?•
*Gary S. Francis, M.D., FACC, Univ. of MN Hosp., Minneapo•
lis, MN 
* + See disclosure statement 
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C 25th Annual Louis F. Bishop Lecture 
10001 414 
Wednesday, March 16, 1994, 2:00 p.m.-3:00 p.m. 
Georgia World Congress Center, Ballroom III 
Chairman: Richard O. Russell, Jr., M.D., FACe., 
Cardiovascular Assoc., Inc., Birmingham, AL 
Plaque Growth and Neo-Microcirculation: Therapeutic 
Challenge and Genetic Opportunity-Valentin Fuster, M.D., 
Ph.D., FACe., Mt. Sinai Med. Ctr., New York, NY 
~ 
620 
Idiopathic Long QT Syndrome-Genes to 
ECG 10001 
Wednesday, March 16, 1994, 2:00 p.m.-3:30 p.m. 
Georgia World Congress Center, 365W 
Co-Chairmen: Ralph Lazzara, M.D., FACe., Univ. of OK Hlth. Sci. 
Ctr., Oklahoma City, OK 
Arthur J. Moss, M.D., FACe., Univ. of Rochester Med. 
Ctr., Rochester, NY 
2:00 Long OT Syndrome-Scope of the Problem-Melvin M. 
Scheinman, M.D., FACe., Univ. of CA-San Francisco, San 
Francisco, CA 
2:15 New Observations on Genetics of LOTS-G. Michael 
Vincent, M.D., FACC, Univ. of UT Hlth. Sci. Ctr., Salt Lake 
City, UT 
2 :30 Mechanism of Torsades de Pointe: Basic-Clinical 
Correlation-Ralph Lazzara, M.D., FACC, Univ. of OK Hlth. 
Sci. Ctr., Oklahoma City, OK 
2:45 Role of Sympathetic Nervous System-Peter J. Schwartz, 
M.D., FACe., Univ. of Pavia, Pavia, ITALY 
3:00 Therapeutic Algorithm of When and How to Treat-Arthur 
J. Moss, M.D., FACe., Univ. of Rochester Med. Ctr., 
Rochester, NY 
III How to Satisfy the Editor 
255 
Wednesday, March 16, 1994, 2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 219E 
Co-Chairmen: Dennis M. Krikler, M.D., FACC, Royal Postgraduate 
Sch., London, UNITED KINGDOM 
III 
256 
Dean T. Mason, M.D., FACC, St. Mary's Med. Ctr., 
San Francisco, CA 
How Does PTCA Compare With Medical 
or Surgical Therapy? Results of the 
Completed Clinical Trials _ 10001 
Wednesday, March 16, 1994,2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 218E 
Co-Chairmen: Robert A. Guyton, M.D., FACC, Emory Univ. Sch. of 
Med., Atlanta, GA 
Alfred Francis Parisi, M.D., FACe., Brown Univ., 
Providence, RI 
JACC February 1994:ii-xxx 
JW1 Howto Program and Troubleshootthe 
••• Third Generation Cardioverter-Defibrillator 
257 _ (ODOj 
Wednesday, March 16, 1994, 2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 204E 
Co-Chairmen: Andrew E. Epstein, M.D., FAe.e., Univ. of AL, 
Birmingham, AL 
Victor Parsonnet, M.D., F Ae.e., Newark Beth Israel 
Hosp., Newark, NJ 
JW1 New Non-I nvasive Methods to Assess 
••• Valve Regurgitation _ (ODOj 
258 
Wednesday, March 16, 1994,2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 216E 
Co-Chairmen: Robert A. Levine, M.D., FAe.e., MA Gen. Hosp., 
Boston, MA 
David J. Sahn, M.D., FAe.e., OR Health Sci. Univ., 
Portland, OR 
Update on the Clinical Role of the New 
JW1 Anti-Thrombin Agents: Hirudin, Hirulog, 
••• and Others _ 10Doj 
259 
Wednesday, March 16, 1994,2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 203E 
Co-Chairmen: Eugene Braunwald, M.D., FAe.e., Brigham & 
Women's Hosp., Boston, MA 
* James H. Chesebro, M.D., FAe.e., MA Gen. Hosp., 
Boston, MA 
III Cardiac Transplantation 
260 
Wednesday, March 16, 1994,2:30 p.m.-3:30 p.m. 
Georgia World Congress Center, 217E 
Co-Chairmen: * Jeffrey D. Hosenpud, M.D., FAe.e., OR Health Sci. 
Univ., Portland, OR 
Hannah A. Valantine, M.D., F.A.e.e., Stanford Univ., 
Stanford, CA 
The American College of Cardiology 
promotes a "No Smoking" policy. The 
use of tobacco products is strictly 
prohibited in all areas of the Conven•
tion Center and all hotel meeting 
rooms hosting A CC events. 
Thank you for not smoking. 
* + See disclosure statement 
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~ Atrial Fibrillation: Management 
621 
Wednesday, March 16, 1994,4:00 p.m.-5:00 p.m. 
Georgia World Congress Center, Ballroom III 
Co-Chairmen: * John Philip Di Marco, M.D., Ph.D., FAe.e., Univ. of 
VA Med. Ctr., Charlottesville, VA 
xxix 
*Gerald V. Naccarelli, M.D., FAe.e., Univ. of TX Med. 
Sch., Houston, TX 
4:00 Ventricular Rate Control: Drugs vs. Catheter Ablation•
* John Philip Di Marco, M.D., Ph.D., FAe.e., Univ. of VA 
Med. Ctr., Charlottesville, VA 
4: 15 Pharmacologic Prevention and Atrial Fibrillation•
*Gerald V. Naccarelli, M.D., FAe.e., Univ. ofTX Med. Sch., 
Houston, TX 
4:30 Indications for Anticoagulation-*Michael D. Ezekowitz, 
M.B., Ch.B., FAe.e., Yale Univ. Sch. of Med., New Haven, 
CT 
4:45 Surgery for Atrial Fibrillation-T. Bruce Ferguson, Jr., 
M.D., Washington Univ., St. Louis, MO 
C 43rd Annual Convocation 
415 
Wednesday, March 16, 1994,6:00 p.m.-7:30 p.m. 
Georgia World Congress Center, Auditorium 
5:30 New Fellows Processional 
Invocation 
Introduction of Distinguished Guests and 
Officers 
Presentation of Awards 
-
Conferring of Fellowships by the President 
Presentation of the Convocation Medal to the 
Convocation Lecturer 
Convocation Lecture: Reflections of Current 
Contentions-William F. Buckley, Jr. 
Installation of the New President 
Recessional 
Reception in Honor of Newly Elected Fellows 
Wednesday, March 16, 1994,7:30 p.m.-8:30 p.m 
Georgia World Congress Center, Ballroom Foyer 
Featuring Robert O. Brandenburg, M.D., FAe.e., Stewart L. 
Nunn, M.D., FAe.e. and J. Ward Kennedy, M.D., FAe.e. 
Dinner Dance 
(Black Tie Optional) 
Wednesday, March 16, 1994,8:30 p.m.-11 :30 p.m. 
Georgia World Congress Center, Ballroom 
Enjoy fine food, lively entertainment, and an unforgettable 
night with friends. 
xxx PROGRAM 
Registration 
Thursday, March 17, 1994, 8:00 a.m.-11 :00 a.m. 
Georgia World Congress Center, Hall E 
~ Disorders of Cardiovascular Aging 
656 
Thursday, March 17, 1994,8:30 a.m.-Noon 
Georgia World Congress Center, Auditorium 
Co-Chairmen: Melvin D. Cheitlin, M .D., FACC, Univ. of CA-San 
Francisco, San Francisco, CA 
Nanette Kass Wenger, M .D., FACC, Emory Univ. Sch. 
of Med., Atlanta, GA 
8:30 Epidemiology of Heart Disease in the Aged-Daniel Levy, 
M .D., FACC, Framingham Heart Study, Framingham, MA 
9:00 Effect of Aging on the Heart-Edward Lakatta, M.D., 
Gerontology Res. Ctr ., Baltimore, MD 
9:30 Effect of Aging on the Vasculature-Daniel E. Forman, M.D., 
Beth Israel Hosp., Boston, MA 
10:00 Break 
10:30 Systolic Hypertension in the Elderly-Marvin Moser, M.D., 
FACC, Yale Univ. Sch . of Med., New Haven, CT 
11 :00 Diastolic Dysfunction in the Elderly-Julius M. Gardin, M.D., 
FACC, Univ. of CA, Irvine, CA 
11 : 30 Management of Cardiac Disorders in the Elderly-Gottlieb 
C Friesinger,lI, M.D. , F.A.CC, Vanderbilt Med. Ctr., Nashvi lle, 
TN 
rmn Biologic Valve Replacement: Use in Adult .1 and Congenital Heart Disease locoj 
622 
Thursday, March 17, 1994,8:30 a.m.-1 0:00 a.m 
Georgia World Congress Center, 314E 
Co-Chairmen: Steven F. Bolling, M .D., FACC, Univ. of MI, Ann 
Arbor, MI 
William A. Gay, Jr., M.D., FACe. , Montefiore Hasp. , 
Bronx, NY 
8:30 Cryopreserved Aortic Homografts: Are They Durable?•
James K. Kirklin, M.D., FACe., Univ. of AL, Birmingham, AL 
8:50 AorticHomografts: The "Total Root Replacement" 
Alternative-*Mark F. O'Brien, F.R.e.S ., Brisbane, AUSTRALIA 
9: 1 0 The Pulmonary Artery Autograft: Long Term Outcome•
Dona ld Nixon Ross, F.R.e.S., FACC, London, UNITED 
KINGDOM 
9:30 The Pulmonary Artery Autograft: Use in Children-Ronald 
Elkins, M.D., Univ. of OK, Oklahoma City, OK 
* + See disclosure statement 
JACC February 1994:ii-xxx 
rmn Single Lung Transplantation in the .1 Treatment of Pulmonary Hypertension 
623 
Thursday, March 17, 1994, 10:30a.m.-Noon 
Georgia World Congress Center, 314E 
Co-Chairmen: Vaughn Starnes, M.D., USC Sch . of Med., Los Angeles, 
CA 
Gus J. Vlahakes, M .D., FAe.C, MA Gen. Hasp., Boston, 
MA 
10:30 Nitric Oxide Gas In the Evaluation and Management of 
Pulmonary Hypertension-David Wessel, M.D., Children's 
Hasp., Boston, MA 
10:45 Lung Transplantation in the Management of Severe 
Pulmonary Hypertension-Francis Wells, M.D., Papworth 
Hosp ., Cambridge, UNITED KINGDOM 
11 :00 Impaired Right Ventricular Function in Pulmonary 
Hypertension: How Much Is Enough?-Marc Semigran, 
M.D., MAGen. Hasp., Boston, MA 
11: 15 The Medical Management Pre- and Postoperatively•
*Robyn J. Barst, M.D., FAe.e., Columbia Univ., New York, NY 
11 :30 Heart Lung Transplantation for Pulmonary Hypertension: 
Is There Still a Role7-Bartley P. Griffith, M.D., Univ. of 
Pittsburgh, Pittsburgh, PA 
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